Investorideas.com - Featured Special Oil and Gas Stock Report; American Petro-hunter Inc (OTCBB: AAPH), written by Grass Roots Research and Distribution, Inc.
"We expect significant growth potential from AAPH's prolific oil and gas projects in Oklahoma and Kansas in the immediate to medium term”- Grass Roots Research and Distribution, Inc.
Visit this company: www.aaphreport.com
Point Roberts, WA - October 22, 2010 The Investorideas.com Energy Newswire and www.OilandGasStocksNews.com publish the following Oil and Gas stock report on American Petro-hunter Inc (OTCBB: AAPH), written by Grass Roots Research and Distribution, Inc.
Investorideas.com features third party research in multiple industry sectors including energy, biotech and mining. More third party research reports can be found at http://www.investorideas.com/Research/.
Full report at www.grassrootsrd.com and http://www.investorideas.com/CO/AAPH/Cohen_AAPH_report_100510.pdf
Report Excerpt:
INVESTMENT THESIS & RECOMMENDATION; Written by Grass Roots Research and Distribution, Inc.
American Petro-Hunter, Inc. (OTCBB: AAPH) is a rapidly growing, expertly managed exploration and production (E&P) company. The Company intends to become an intermediate level oil and gas producer within the next 12 months. AAPH's business strategy is based on acquiring and developing high quality projects with existing and expansion potential. The Company is currently focused on expanding its acreages/ leases at its North Oklahoma Project and building a strong, balanced and diversified portfolio of oil and gas assets. American Petro is revenue positive and is in production at its Poston Project.
American Petro-Hunter intends to become a 500-1000 BOE producer in the next 12-36 months by aggressively developing its Poston and North Oklahoma Oil Project as well as continuing to engage in exploratory drilling opportunities on its Colby Prospect and Sacramento Gas Prospect. The Company further intends to expand its acreages across North America.
Key corporate value drivers include: discovery of a new oil field, existing production capabilities, a balanced portfolio of assets, favorable industry economics, recent funding arrangement and a strong management team. Providing the Company raises approximately $5.0 million of total capital, we forecast significant top line growth. Revenues are expected to grow from $0.5 million FYE December 31, 2010 to more than $11.8 million by FYE 2014. AAPH is potentially a lucrative investment opportunity in the oil and gas E&P space and provides an upside potential of 191.3% in the short term and long term.
COMPANY VALUE PROPOSITION
Balanced Portfolio of Assets
Company's projects are located in areas which are highly prolific and produce large quantities of oil and gas.
The Company's proposed projects will explore and develop oil & gas, from conventional resources primarily in United States and Canada.
Favorable Industry Economics
Demand for oil & gas is likely to grow significantly driven by demand from developing nations
Existing infrastructure makes it easier for the Company to market its products.
Use of Modern Technology
Using modern technology in the exploration and production activities will help the Company improve productivity and profitability.
Strong Management Team
AAPH has consistently built a team of geologists and executives who are experts in this field.
Management equipped with ability to drive growth and rapidly evolve the Company.
"American Petro-Hunter is building a strong, balanced and diversified portfolio of oil and gas assets that will result in significant reserve growth, production revenue and value for shareholders. The Company is well positioned to benefit from a current strong increase in oil prices. AAPH will need to raise the necessary initial capital to initiate drilling activities and expand its property base. As previously mentioned, the Company plans to invest up to $5.0 million in the next 24-months for exploration and development of its projects. The recent funding of $1.5 million from Maxum Overseas Funds shall enable AAPH to continue the development of its oil and gas projects, specifically in the near term in Kansas and the North Oklahoma Project, land leasing and for general administration going forward. We expect long term upside revenue opportunities from the Company's portfolio of assets, highly scalable business model, and new acquisition deals as oil and gas prices continue to rise. American Petro Hunter is an exciting oil and gas exploration and production company providing significant short term and long term investment opportunity for risk-averse investors.”
COMPANY PROJECT DESCRIPTION
The Company has a diversified and balanced a portfolio of assets with two production and one field development properties in Kansas, seven oil projects in Oklahoma and one gas prospect in California. American Petro-Hunter's Poston Project, Trego County, Kansas is already in-production. The Company has also recently initiated production at one of its seven leases in North Oklahoma. Other prospects include: Colby Prospect, Thomas County, Kansas; and Sacramento Gas Prospect, Central Valley, California.
North Oklahoma Oil Project, Oklahoma2
American Petro Hunter has acquired a working interest in an exciting oil play located in the northern part of the state. The Project targets regional shale formations rich in oil. Currently, the Company is drilling shallow, vertical wells with future plans to exploit the shale productive horizon with horizontal drilling. Individual wells at the analogous Bakken formation in North Dakota are producing over 2,000 barrels per day from staged fracture stimulation programs. The North Oklahoma Project pursues production of high gravity light oil above 3800 feet with estimated oil production in the 150 to 550 BPD range as anticipated Initial Production Rates. NOJ26 is a 4000 foot vertical well targeting multiple objectives including our 48 foot shale target plus both the Simpson and Wilcox formations one of the most prolific producers in Payne County Nearby existing analog production has produced a cumulative 80,000 barrels of oil per well with 7 years of commercial activity to date. Wilcox wells often deliver initial production rates in excess of 100-120 BOPD with 200 MCF of gas. Multiple objectives minimize risk given the three potentially productive horizons. No. 1 well returned rates in the 75-85 BPD rates on acidization and a similar technique may prove to be the most cost effective path to R.O.I and payback. Fracture stimulation at a later date may be indicated. NOJ26 is anticipated as a 200 plus BPD producer. A horizontal well drilled laterally down and along the Woodford shale will expose over 1,500 feet of rock that upon stimulation should produce large quantities of oil. Engineering estimates of the potential of a successful horizontal well at the North Oklahoma Project could be 500 BPD per well. The oil from the Woodford shale is light, high quality crude and we have big plans in the future for more horizontals. The southern part of our lease block has room to drill up to 5 horizontals in the shale and also up to 25 conventional vertical wells if our program successfully finds oil from previously identified and prolific formations such as the Simpson and Wilcox.
Grass Roots Research and Distribution, Inc. CONCLUSION:
"....We expect significant growth potential from AAPH's prolific oil and gas projects in Oklahoma and Kansas in the immediate to medium term. The prospects of the Company have further brightened after it went in-production at its core acreage at the Northern Oklahoma Project and the Rooney Prospect. This will expedite revenue growth and increase free cash flows, thus providing the capital expansion and commercialization of its other projects. Revenues are expected to grow from $0.5 million for Fiscal Year End (FYE) December 31, 2010 to more than $11.8 million by FYE 2014. Note: our projections assume that the Company will be able to achieve our forecasted targets provided it raises a total of $5.0 million funding.
The quality of the portfolio's assets is excellent. We believe this quality together with the experience and proven track record of its management team will enable enhanced returns on investment. The Company intends to become an intermediate level oil and gas producer. It will achieve this level as a producer by acquiring and developing high quality projects with existing production and expansion potential. In addition it will possess defined-risk developmental and exploratory drilling opportunities. American Petro-Hunter provides an exciting short term and long term investment opportunity.”
To read full article please check out www.grassrootsrd.com and http://www.investorideas.com/CO/AAPH/Cohen_AAPH_report_100510.pdf
American Petro-hunter Inc (OTCBB: AAPH) is a showcase Oil and Gas stock on Investorideas.com (please read disclosure and disclaimers)
Visit the showcase page on Investorideas.comhttp://www.investorideas.com/CO/AAPH/
Request info:http://www.investorideas.com/Resources/Newsletter.asp
About our Oil and Gas portal:
www.OilandGasStocksNews.com is a global meeting place for investors and industry following the energy sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our oil and gas and natural gas stock directories.
Disclaimer: The following American Petro-Hunter Inc news is paid for by third party on behalf of showcase energy stock AAPH (three thousand per month). Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
The research report is the content and opinion of Grass Roots Research and Distribution, Inc.Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
C Van Zant: 800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Connect with Investorideas.com
Publish Your News - Send a release
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Monday, October 25, 2010
Investorideas.com - Penny Stock Leaders on OTC ($0.14 - $0.25); (OTCBB: CBIS, DYER, CHTL, LIEGE)
Investorideas.com - Penny Stock Leaders on OTC ($0.14 - $0.25); (OTCBB: CBIS, DYER, CHTL, LIEGE)
Note to Editors: The Following Is an Investment Opinion Being Issued by OTC VOLUME LEADERS
Category: Investment, Financial
Share this news:
Visit this company: www.otcvolumeleaders.com
Point Roberts, WA (Investorideas.com Newswire) October 25, 2010 - OTC VOLUME LEADERS reports on the most recent active trading penny stocks on the OTCBB for interested investors. OTC Volume leaders ($0.14-$0.25) included; CANNABIS SCIENCE INC (OTCBB: CBIS) and DYNASTY ENERGY RES (OTCBB: DYER).
Sign up for Tomorrows Hot OTC Market Leaders Today!Email:
Cannabis Science, Inc. (CBIS.OB) had traded over 3 million shares in early morning trading at the time of this release.
More info:
Investors: Sign up at OTC Volume leaders and get access to info on hundreds of the most active OTCBB companies by clicking the sign up link belowhttp://bit.ly/otcvolumeleaders
MOST ACTIVE $0.14 - $0.25 - Top 10
CBIS
DYER
CHTL
LIEGE
JYHW
IWEB
DUNR
SGCA
ARDM
ERHE
OTC/Market Commentary: News moving OTC Leaders
Sectors include China stocks and energy stocks
Market Snapshot: (at time of release)Commodities
Crude Oil Dec 10 83.00 +1.41 Crude Oil Dec 10
Gold Oct 10 1,336.00 +11.60 Gold Oct 10
Natural Gas Nov 10 3.29 -0.04 Natural Gas Nov 10
RBOB Gasoline Nov 10
OTCBB Investors: Take the few minutes to register with us at To sign up for free Newsletter http://bit.ly/otcvolumeleaders and get access to info on hundreds of the most active OTCBB companies and keep up to date with developments of the companies.
OTC VOLUME LEADERS provides investors with daily market updates showcasing the most actively traded OTCBB Companies. We strive to provide you with the most up-to-date market information and activity by searching through hundreds of OTCBB companies in order to provide you information on the best of these companies. The goal is to continually find tomorrow’s market leading companies, today!
OTCVolumeleaders.com has not been compensated by any of the above mentioned companies. We act as an independent research portal and are aware that all investment entails inherent risks.
Please view the full disclaimer: http://www.otcvolumeleaders.com/Source http://www.otcvolumeleaders.com/Follow OTC Volume Leaders on Twitter.com http://twitter.com/OTCVolumeLeader
* Attention Investors in British Columbia Canada: Do not subscribe to any OTC stocks not currently filing with Sedar in BC and BC Securities
Visit the OTC showcase profile at Investorideas.com Request News and Info on OTC Investors - Get OTC stock quotes from http://www.otcmarkets.com Disclosure, Disclaimer/ OTC is a paid advertising client on Investorideas.com.
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Connect with Investorideas.com
Publish Your News - Send a release
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Note to Editors: The Following Is an Investment Opinion Being Issued by OTC VOLUME LEADERS
Category: Investment, Financial
Share this news:
Visit this company: www.otcvolumeleaders.com
Point Roberts, WA (Investorideas.com Newswire) October 25, 2010 - OTC VOLUME LEADERS reports on the most recent active trading penny stocks on the OTCBB for interested investors. OTC Volume leaders ($0.14-$0.25) included; CANNABIS SCIENCE INC (OTCBB: CBIS) and DYNASTY ENERGY RES (OTCBB: DYER).
Sign up for Tomorrows Hot OTC Market Leaders Today!Email:
Cannabis Science, Inc. (CBIS.OB) had traded over 3 million shares in early morning trading at the time of this release.
More info:
Investors: Sign up at OTC Volume leaders and get access to info on hundreds of the most active OTCBB companies by clicking the sign up link belowhttp://bit.ly/otcvolumeleaders
MOST ACTIVE $0.14 - $0.25 - Top 10
CBIS
DYER
CHTL
LIEGE
JYHW
IWEB
DUNR
SGCA
ARDM
ERHE
OTC/Market Commentary: News moving OTC Leaders
Sectors include China stocks and energy stocks
Market Snapshot: (at time of release)Commodities
Crude Oil Dec 10 83.00 +1.41 Crude Oil Dec 10
Gold Oct 10 1,336.00 +11.60 Gold Oct 10
Natural Gas Nov 10 3.29 -0.04 Natural Gas Nov 10
RBOB Gasoline Nov 10
OTCBB Investors: Take the few minutes to register with us at To sign up for free Newsletter http://bit.ly/otcvolumeleaders and get access to info on hundreds of the most active OTCBB companies and keep up to date with developments of the companies.
OTC VOLUME LEADERS provides investors with daily market updates showcasing the most actively traded OTCBB Companies. We strive to provide you with the most up-to-date market information and activity by searching through hundreds of OTCBB companies in order to provide you information on the best of these companies. The goal is to continually find tomorrow’s market leading companies, today!
OTCVolumeleaders.com has not been compensated by any of the above mentioned companies. We act as an independent research portal and are aware that all investment entails inherent risks.
Please view the full disclaimer: http://www.otcvolumeleaders.com/Source http://www.otcvolumeleaders.com/Follow OTC Volume Leaders on Twitter.com http://twitter.com/OTCVolumeLeader
* Attention Investors in British Columbia Canada: Do not subscribe to any OTC stocks not currently filing with Sedar in BC and BC Securities
Visit the OTC showcase profile at Investorideas.com Request News and Info on OTC Investors - Get OTC stock quotes from http://www.otcmarkets.com Disclosure, Disclaimer/ OTC is a paid advertising client on Investorideas.com.
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Connect with Investorideas.com
Publish Your News - Send a release
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Investorideas.com - Sport Distributor Deploys UV Flu Technologies (OTCBB: UVFT) Air Purifying Units For Well-Known Hockey Team's Locker Room
Investorideas.com - Sport Distributor Deploys UV Flu Technologies (OTCBB: UVFT) Air Purifying Units For Well-Known Hockey Team's Locker Room
"This is the second professional hockey team to put the UV-400 in their locker rooms, along with several college hockey teams," stated Charles Gulteri, President of NESSI (New England Sports Sales)
Visit this company: www.uvflutech.com
CENTERVILLE, MA - October 25, 2010 (InvestorIdeas.com Newswire, www.biotechindustrystocks.com) - UV Flu Technologies, Inc. (OTC.BB:UVFT) reports New England Sports Sales ("NESSI"), a national distributor of hockey and related equipment to college and professional hockey teams across the USA and Canada, has recently placed an order for ViraTech UV-400 air purifying units in the locker room of the renowned Boston Bruins hockey team.
"This is the second professional hockey team to put the UV-400 in their locker rooms, along with several college hockey teams," stated Charles Gulteri, President of NESSI. "Teams at this level of competition are acutely aware that healthy players are critical for a winning effort. Losing key players in-season for several games due to sickness that could have been avoided is costly and needs to be prevented using every effective tool commercially available.
The ViraTech UV-400 kills bacteria and other contaminants, which are rampant in locker rooms, as well as controlling odors. The UV-400's ability to dramatically reduce odors is a really helpful benefit in the close quarters of a locker room, especially given the access commonly granted to reporters and other special guests. We think this unit could become standard operating equipment in locker rooms around the world." said Mr. Gulteri.
"Athletic locker rooms are becoming a surprisingly robust area of interest for our product," said Jack Lennon, President of UV Flu Technologies. "Players are travelling by plane constantly, so they are very susceptible to respiratory illnesses that they pick up while travelling and then pass on by sneezing and coughing in the locker room. Not only does this cause other players to get sick, the illness can be inflamed by the many volatile organic compounds used in the locker rooms, from rubbing alcohol, through muscle relaxants, bathroom cleaning solvents, etc. The UV-400 kills over 99% of airborne bacteria and other contaminants with every pass, while also dramatically reducing the concentration and effect of these volatile organic compounds, including odors. We believe the market for our product in this market segment, along with our ongoing sales to the hotel and medical community may compel us to pro-actively increase our production estimates for the UV-400 over the next 18 months," said Mr. Lennon.
Further details regarding the Company's business, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database. For more information, visit: www.uvflutech.com. For sales: www.puravair.com
About UV Flu Technologies, Inc. (OTC.BB:UVFT)
UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector (over $7.7 billion in 2008). The Company manufactures the ViraTech UV-400, which utilizes high-intensity ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria, at rates exceeding 99.2% on a first-pass basis, while also reducing the concentrations of odors, and VOC's (volatile organic compounds, such as acetone, benzene, formaldehyde, etc.) The FDA has issued a coveted Class II medical listing that enables UV Flu Technologies to market the product as a medical device. For more information, visit: www.uvflutech.com. For sales: www.puravair.com.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
UV Flu Technologies, Inc.
John J. Lennon, President & CEO
Contact:
Investor Information:
Geaux IR Services, Inc.
Toll-Free: 1-888-355-8838
investors@uvflutech.com
SOURCE: UV Flu Technologies, Inc.
UV Flu Technologies (OTCBB: UVFT) is a showcase biotech stock on Investorideas.com (please read disclosure and disclaimers)
Visit the showcase page on Investorideas.com
http://www.investorideas.com/CO/UVFT/
Request info:
http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.
About our Biotech investor portal: www.biotechindustrystocks.com
BiotechIndustryStocks.com is a global meeting place for investors and industry following the sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our stock directories.
Disclaimer: The following news is paid for by third party on behalf of UV Flu Technologies, Inc., (three thousand per month) Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
More Investorideas Biotech Stocks info wwww.BiotechIndustryStocks.com - A Leading Global Investor Website for Biotech Industry Stocks, Biotech, Pharma and Industry News and Biotech Investor Research Tools including a Biotech Stocks Directory
Biotech Companies - become a biotech showcase stock on www.investorideas.com and www.biotechindustrystocks.com for as little as $1000 month !
"This is the second professional hockey team to put the UV-400 in their locker rooms, along with several college hockey teams," stated Charles Gulteri, President of NESSI (New England Sports Sales)
Visit this company: www.uvflutech.com
CENTERVILLE, MA - October 25, 2010 (InvestorIdeas.com Newswire, www.biotechindustrystocks.com) - UV Flu Technologies, Inc. (OTC.BB:UVFT) reports New England Sports Sales ("NESSI"), a national distributor of hockey and related equipment to college and professional hockey teams across the USA and Canada, has recently placed an order for ViraTech UV-400 air purifying units in the locker room of the renowned Boston Bruins hockey team.
"This is the second professional hockey team to put the UV-400 in their locker rooms, along with several college hockey teams," stated Charles Gulteri, President of NESSI. "Teams at this level of competition are acutely aware that healthy players are critical for a winning effort. Losing key players in-season for several games due to sickness that could have been avoided is costly and needs to be prevented using every effective tool commercially available.
The ViraTech UV-400 kills bacteria and other contaminants, which are rampant in locker rooms, as well as controlling odors. The UV-400's ability to dramatically reduce odors is a really helpful benefit in the close quarters of a locker room, especially given the access commonly granted to reporters and other special guests. We think this unit could become standard operating equipment in locker rooms around the world." said Mr. Gulteri.
"Athletic locker rooms are becoming a surprisingly robust area of interest for our product," said Jack Lennon, President of UV Flu Technologies. "Players are travelling by plane constantly, so they are very susceptible to respiratory illnesses that they pick up while travelling and then pass on by sneezing and coughing in the locker room. Not only does this cause other players to get sick, the illness can be inflamed by the many volatile organic compounds used in the locker rooms, from rubbing alcohol, through muscle relaxants, bathroom cleaning solvents, etc. The UV-400 kills over 99% of airborne bacteria and other contaminants with every pass, while also dramatically reducing the concentration and effect of these volatile organic compounds, including odors. We believe the market for our product in this market segment, along with our ongoing sales to the hotel and medical community may compel us to pro-actively increase our production estimates for the UV-400 over the next 18 months," said Mr. Lennon.
Further details regarding the Company's business, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database. For more information, visit: www.uvflutech.com. For sales: www.puravair.com
About UV Flu Technologies, Inc. (OTC.BB:UVFT)
UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector (over $7.7 billion in 2008). The Company manufactures the ViraTech UV-400, which utilizes high-intensity ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria, at rates exceeding 99.2% on a first-pass basis, while also reducing the concentrations of odors, and VOC's (volatile organic compounds, such as acetone, benzene, formaldehyde, etc.) The FDA has issued a coveted Class II medical listing that enables UV Flu Technologies to market the product as a medical device. For more information, visit: www.uvflutech.com. For sales: www.puravair.com.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
UV Flu Technologies, Inc.
John J. Lennon, President & CEO
Contact:
Investor Information:
Geaux IR Services, Inc.
Toll-Free: 1-888-355-8838
investors@uvflutech.com
SOURCE: UV Flu Technologies, Inc.
UV Flu Technologies (OTCBB: UVFT) is a showcase biotech stock on Investorideas.com (please read disclosure and disclaimers)
Visit the showcase page on Investorideas.com
http://www.investorideas.com/CO/UVFT/
Request info:
http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.
About our Biotech investor portal: www.biotechindustrystocks.com
BiotechIndustryStocks.com is a global meeting place for investors and industry following the sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our stock directories.
Disclaimer: The following news is paid for by third party on behalf of UV Flu Technologies, Inc., (three thousand per month) Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
More Investorideas Biotech Stocks info wwww.BiotechIndustryStocks.com - A Leading Global Investor Website for Biotech Industry Stocks, Biotech, Pharma and Industry News and Biotech Investor Research Tools including a Biotech Stocks Directory
Biotech Companies - become a biotech showcase stock on www.investorideas.com and www.biotechindustrystocks.com for as little as $1000 month !
Tuesday, October 19, 2010
Investorideas.com - Biotechnology Stocks; UV Flu Technologies (OTCBB: UVFT) UV-400 Air Purifier Chosen by XV Beacon Hotel
Investorideas.com - Biotechnology Stocks; UV Flu Technologies (OTCBB: UVFT) UV-400 Air Purifier Chosen by XV Beacon Hotel
UV-400 Air Purifier Selected for new Hypo-Allergenic Program as Health Oriented Enhancement
Category: Investment, Biotech
Visit this company: www.uvflutech.com
CENTERVILLE, MA - October 19, 2010 (Investorideas.com newswire, www.biotechindustrystocks.com) Biotechnology Stock News; UV Flu Technologies, Inc. (OTC.BB:UVFT) reports the Boston's XV Beacon Hotel has chosen the UV-400 bacteria killing air purifier as an added value offering to their guests as a health oriented enhancement available at their multi award winning prestige property.
The XV Beacon Hotel (www.xvbeacon.com) is a 2010 recipient of a Condé Nast award of excellence, and was ranked in 2009 as "#4 Top 20 Business Hotel in the World" by Travel & Leisure Magazine, and "#5 World's Best Small Hotel: US and Canada" by Travel & Leisure Magazine, alongside numerous awards from industry leading advisors such as Fodor's, Forbes Traveller, American Express and many others.
Hotel management noted that, "Cold and flu season may be coming on strong, but for allergy sufferers the battle against sniffles and watery eyes never ends. Now XV Beacon in Boston is taking up arms for severely allergic guests with NEW Hypo-Allergenic Guest Rooms courtesy of the ViraTech UV-400 advanced air purification system. This is just the latest example of how the award-winning boutique hotel on Beacon Hill puts the comfort of its guests above everything else."
The ViraTech UV-400 is a breath of fresh air for severely allergic guests. Approved by Edison Testing Laboratories and certified as a medical device by the FDA, the otherwise inconspicuous air filter kills more than 99% of indoor airborne bacteria while significantly reducing sinus-irritating particles and odors.
The XV Beacon plans to employ the ViraTech UV-400 upon request to "prep" guest rooms for a one-hour period prior to arrival on a complimentary basis and for a small fee will make the unit available for continuous use to ensure their room remains nearly allergen-free throughout their entire stay.
UV Flu Technologies Company President & CEO John J. Lennon stated, "As we head toward the time of year where holiday travel plans coincide with the onset of flu and cold season, the efficacy of our product can offer concerned hotel guests newer, healthier choices never before available when it comes to making their accommodation plans. We are thrilled that such a well-regarded property as the XV Beacon has the vision and leadership to see the potential benefits our product can provide their guests both at this time of year, but especially for allergy sufferers year round. We anticipate this market segment to grow exponentially as other properties grasp the significance of this new technology as we head towards 2011."
Further details regarding the Company's business, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.
About UV Flu Technologies, Inc. (OTC.BB:UVFT)
UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector. The Company manufactures the ViraTech UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. The product also is highly effective in reducing odors and VOC's, or Volatile Organic Compounds, such as acetone, benzene and formaldehyde. ViraTech UV-400 is a Class II medical device and is available without a prescription.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
UV Flu Technologies, Inc.
John J. Lennon, President & CEO
Contact:
Investor Information:
Geaux IR Services, Inc.
Toll-Free: 1-888-355-8838
investors@uvflutech.com
Visit the UVFT showcase profile at Investorideas.com
Request News and Info on UVFT
Disclosure, Disclaimer/ UVFT is a paid advertising client on Investorideas.com. (showcase biotech stock for one month advertising three thousand)
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
More Investorideas Biotech Stocks info wwww.BiotechIndustryStocks.com -
A Leading Global Investor Website for Biotech Industry Stocks, Biotech, Pharma and Industry News and Biotech Investor Research Tools including a Biotech Stocks DirectoryBiotech Companies - become a biotech showcase stock on www.investorideas.com and www.biotechindustrystocks.com for as little as $1000 month !
UV-400 Air Purifier Selected for new Hypo-Allergenic Program as Health Oriented Enhancement
Category: Investment, Biotech
Visit this company: www.uvflutech.com
CENTERVILLE, MA - October 19, 2010 (Investorideas.com newswire, www.biotechindustrystocks.com) Biotechnology Stock News; UV Flu Technologies, Inc. (OTC.BB:UVFT) reports the Boston's XV Beacon Hotel has chosen the UV-400 bacteria killing air purifier as an added value offering to their guests as a health oriented enhancement available at their multi award winning prestige property.
The XV Beacon Hotel (www.xvbeacon.com) is a 2010 recipient of a Condé Nast award of excellence, and was ranked in 2009 as "#4 Top 20 Business Hotel in the World" by Travel & Leisure Magazine, and "#5 World's Best Small Hotel: US and Canada" by Travel & Leisure Magazine, alongside numerous awards from industry leading advisors such as Fodor's, Forbes Traveller, American Express and many others.
Hotel management noted that, "Cold and flu season may be coming on strong, but for allergy sufferers the battle against sniffles and watery eyes never ends. Now XV Beacon in Boston is taking up arms for severely allergic guests with NEW Hypo-Allergenic Guest Rooms courtesy of the ViraTech UV-400 advanced air purification system. This is just the latest example of how the award-winning boutique hotel on Beacon Hill puts the comfort of its guests above everything else."
The ViraTech UV-400 is a breath of fresh air for severely allergic guests. Approved by Edison Testing Laboratories and certified as a medical device by the FDA, the otherwise inconspicuous air filter kills more than 99% of indoor airborne bacteria while significantly reducing sinus-irritating particles and odors.
The XV Beacon plans to employ the ViraTech UV-400 upon request to "prep" guest rooms for a one-hour period prior to arrival on a complimentary basis and for a small fee will make the unit available for continuous use to ensure their room remains nearly allergen-free throughout their entire stay.
UV Flu Technologies Company President & CEO John J. Lennon stated, "As we head toward the time of year where holiday travel plans coincide with the onset of flu and cold season, the efficacy of our product can offer concerned hotel guests newer, healthier choices never before available when it comes to making their accommodation plans. We are thrilled that such a well-regarded property as the XV Beacon has the vision and leadership to see the potential benefits our product can provide their guests both at this time of year, but especially for allergy sufferers year round. We anticipate this market segment to grow exponentially as other properties grasp the significance of this new technology as we head towards 2011."
Further details regarding the Company's business, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.
About UV Flu Technologies, Inc. (OTC.BB:UVFT)
UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector. The Company manufactures the ViraTech UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. The product also is highly effective in reducing odors and VOC's, or Volatile Organic Compounds, such as acetone, benzene and formaldehyde. ViraTech UV-400 is a Class II medical device and is available without a prescription.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
UV Flu Technologies, Inc.
John J. Lennon, President & CEO
Contact:
Investor Information:
Geaux IR Services, Inc.
Toll-Free: 1-888-355-8838
investors@uvflutech.com
Visit the UVFT showcase profile at Investorideas.com
Request News and Info on UVFT
Disclosure, Disclaimer/ UVFT is a paid advertising client on Investorideas.com. (showcase biotech stock for one month advertising three thousand)
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
More Investorideas Biotech Stocks info wwww.BiotechIndustryStocks.com -
A Leading Global Investor Website for Biotech Industry Stocks, Biotech, Pharma and Industry News and Biotech Investor Research Tools including a Biotech Stocks DirectoryBiotech Companies - become a biotech showcase stock on www.investorideas.com and www.biotechindustrystocks.com for as little as $1000 month !
Investorideas.com - Oil and Gas Stocks; American Petro-Hunter (OTCBB: AAPH) Updates NOJ26 Well Completion Progress -- No.1 Well Producing at North Oklahoma Project
Investorideas.com - Oil and Gas Stocks; American Petro-Hunter (OTCBB: AAPH) Updates NOJ26 Well Completion Progress -- No.1 Well Producing at North Oklahoma Project
Visit this company: www.aaphreport.com
SCOTTSDALE, AZ - October 19, 2010 (Investorideas.com energy newswire) - American Petro-Hunter, Inc. (OTCBB: AAPH) ("American Petro-Hunter" or the "Company") is pleased to update the ongoing well completion progress at the NOJ26 Well location on the North Oklahoma Oil Project.
NOJ26 was successfully perforated and acidized in the lower oil bearing shale horizon where high gravity light oil was recovered and swabbed with excellent oil cut over the 40 foot interval. The shale will now undergo fracturing in order to finish the stimulation of the lower formation prior to continuation of the well completion program. Shale samples are currently being evaluated at an Oklahoma core lab and the results of this analysis will recommend the optimal fracture stimulation to maximize the oil production from the shale. Results are expected shortly and the final completion of the well is expected to result in commercial production by month end. The pumping unit and tank battery is now on site for rapid tie-in and hook up of NOJ26 well.
The Company is confident that based on strong oil shows and excellent swab testing results that following the fracture stimulation of the shale, the lower shale pay zone will produce at rates in excess of the No. 1 well which tested at 80 BPD under similar conditions. Engineers believe flow rates from the oil shale zone combined with the upper pay zone could ultimately result in over 200 BPD of production at NOJ26. American Petro-Hunter is a 50% partner in the well.
In related news, the Company is further pleased to announce that the No. 1 well at the North Oklahoma project has resumed production and oil is now flowing to the tanks. After a period of stabilization of barrel per day (BPD) rates derived from the oil shale production, the Company plans to begin a reservoir engineering assessment by a third party engineer in order to calculate a reserve estimate of barrels of oil in place under the No. 1 well location.
About American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the ?hunt? for domestic petroleum assets. Visit us at: www.americanpetrohunter.com
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of our exploration program at our properties and any anticipated future production. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with petroleum exploration and development stage exploration companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the most recent fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
American Petro-Hunter, Inc.
Robert McIntosh
President & C.E.O.
To find out more about American Petro-Hunter, Inc. (OTCBB: AAPH), visit our website at www.americanpetrohunter.com
Contact:
Mountainview IR Services, Inc.
1-888-521-7762
investors@americanpetrohunterinc.com
Visit the AAPH showcase profile at Investorideas.com
Request News and Info on AAPH
Disclosure, Disclaimer/ AAPH is a paid advertising client on Investorideas.com.
American Petro-hunter Inc. (AAPH.OB) Oct 2010 - one month showcase energy stock on Investorideas.com and energy portals and blogs (three thousand per month)
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Visit this company: www.aaphreport.com
SCOTTSDALE, AZ - October 19, 2010 (Investorideas.com energy newswire) - American Petro-Hunter, Inc. (OTCBB: AAPH) ("American Petro-Hunter" or the "Company") is pleased to update the ongoing well completion progress at the NOJ26 Well location on the North Oklahoma Oil Project.
NOJ26 was successfully perforated and acidized in the lower oil bearing shale horizon where high gravity light oil was recovered and swabbed with excellent oil cut over the 40 foot interval. The shale will now undergo fracturing in order to finish the stimulation of the lower formation prior to continuation of the well completion program. Shale samples are currently being evaluated at an Oklahoma core lab and the results of this analysis will recommend the optimal fracture stimulation to maximize the oil production from the shale. Results are expected shortly and the final completion of the well is expected to result in commercial production by month end. The pumping unit and tank battery is now on site for rapid tie-in and hook up of NOJ26 well.
The Company is confident that based on strong oil shows and excellent swab testing results that following the fracture stimulation of the shale, the lower shale pay zone will produce at rates in excess of the No. 1 well which tested at 80 BPD under similar conditions. Engineers believe flow rates from the oil shale zone combined with the upper pay zone could ultimately result in over 200 BPD of production at NOJ26. American Petro-Hunter is a 50% partner in the well.
In related news, the Company is further pleased to announce that the No. 1 well at the North Oklahoma project has resumed production and oil is now flowing to the tanks. After a period of stabilization of barrel per day (BPD) rates derived from the oil shale production, the Company plans to begin a reservoir engineering assessment by a third party engineer in order to calculate a reserve estimate of barrels of oil in place under the No. 1 well location.
About American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the ?hunt? for domestic petroleum assets. Visit us at: www.americanpetrohunter.com
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of our exploration program at our properties and any anticipated future production. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with petroleum exploration and development stage exploration companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the most recent fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
American Petro-Hunter, Inc.
Robert McIntosh
President & C.E.O.
To find out more about American Petro-Hunter, Inc. (OTCBB: AAPH), visit our website at www.americanpetrohunter.com
Contact:
Mountainview IR Services, Inc.
1-888-521-7762
investors@americanpetrohunterinc.com
Visit the AAPH showcase profile at Investorideas.com
Request News and Info on AAPH
Disclosure, Disclaimer/ AAPH is a paid advertising client on Investorideas.com.
American Petro-hunter Inc. (AAPH.OB) Oct 2010 - one month showcase energy stock on Investorideas.com and energy portals and blogs (three thousand per month)
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Investorideas.com - Oil and Gas Stocks; American Petro-Hunter (OTCBB: AAPH) Updates NOJ26 Well Completion Progress -- No.1 Well Producing at North Oklahoma Project
Visit this company: http://www.aaphreport.com/
SCOTTSDALE, AZ - October 19, 2010 (Investorideas.com energy newswire) - American Petro-Hunter, Inc. (OTCBB: AAPH) ("American Petro-Hunter" or the "Company") is pleased to update the ongoing well completion progress at the NOJ26 Well location on the North Oklahoma Oil Project.
NOJ26 was successfully perforated and acidized in the lower oil bearing shale horizon where high gravity light oil was recovered and swabbed with excellent oil cut over the 40 foot interval. The shale will now undergo fracturing in order to finish the stimulation of the lower formation prior to continuation of the well completion program. Shale samples are currently being evaluated at an Oklahoma core lab and the results of this analysis will recommend the optimal fracture stimulation to maximize the oil production from the shale. Results are expected shortly and the final completion of the well is expected to result in commercial production by month end. The pumping unit and tank battery is now on site for rapid tie-in and hook up of NOJ26 well.
The Company is confident that based on strong oil shows and excellent swab testing results that following the fracture stimulation of the shale, the lower shale pay zone will produce at rates in excess of the No. 1 well which tested at 80 BPD under similar conditions. Engineers believe flow rates from the oil shale zone combined with the upper pay zone could ultimately result in over 200 BPD of production at NOJ26. American Petro-Hunter is a 50% partner in the well.
In related news, the Company is further pleased to announce that the No. 1 well at the North Oklahoma project has resumed production and oil is now flowing to the tanks. After a period of stabilization of barrel per day (BPD) rates derived from the oil shale production, the Company plans to begin a reservoir engineering assessment by a third party engineer in order to calculate a reserve estimate of barrels of oil in place under the No. 1 well location.
About American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the ?hunt? for domestic petroleum assets. Visit us at: www.americanpetrohunter.com
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of our exploration program at our properties and any anticipated future production. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with petroleum exploration and development stage exploration companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the most recent fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
American Petro-Hunter, Inc.
Robert McIntosh
President & C.E.O.
To find out more about American Petro-Hunter, Inc. (OTCBB: AAPH), visit our website at www.americanpetrohunter.com
Contact:
Mountainview IR Services, Inc.
1-888-521-7762
investors@americanpetrohunterinc.com
Visit the AAPH showcase profile at Investorideas.com
Request News and Info on AAPH
Disclosure, Disclaimer/ AAPH is a paid advertising client on Investorideas.com.
American Petro-hunter Inc. (AAPH.OB) Oct 2010 - one month showcase energy stock on Investorideas.com and energy portals and blogs (three thousand per month)
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
More Investorideas.com Oil and Gas Investor content : http://www.oilandgasstocknews.com/
an energy stocks investor portal within InvestorIdeas.com provides investor research, energy stocks and industry commentary from Karl Miller, stock news and energy links as well as a directory of public companies within the oil and gas sector. Investors can follow energy news by subscribing to the energy stocks newswire at: http://www.investorideas.com/RSS/feeds/Energy.xml
Oil and gas stocks - become a showcase energy stock on www.investorideas.com and its energy portals and blogs for as little as $1000 month !
Visit this company: http://www.aaphreport.com/
SCOTTSDALE, AZ - October 19, 2010 (Investorideas.com energy newswire) - American Petro-Hunter, Inc. (OTCBB: AAPH) ("American Petro-Hunter" or the "Company") is pleased to update the ongoing well completion progress at the NOJ26 Well location on the North Oklahoma Oil Project.
NOJ26 was successfully perforated and acidized in the lower oil bearing shale horizon where high gravity light oil was recovered and swabbed with excellent oil cut over the 40 foot interval. The shale will now undergo fracturing in order to finish the stimulation of the lower formation prior to continuation of the well completion program. Shale samples are currently being evaluated at an Oklahoma core lab and the results of this analysis will recommend the optimal fracture stimulation to maximize the oil production from the shale. Results are expected shortly and the final completion of the well is expected to result in commercial production by month end. The pumping unit and tank battery is now on site for rapid tie-in and hook up of NOJ26 well.
The Company is confident that based on strong oil shows and excellent swab testing results that following the fracture stimulation of the shale, the lower shale pay zone will produce at rates in excess of the No. 1 well which tested at 80 BPD under similar conditions. Engineers believe flow rates from the oil shale zone combined with the upper pay zone could ultimately result in over 200 BPD of production at NOJ26. American Petro-Hunter is a 50% partner in the well.
In related news, the Company is further pleased to announce that the No. 1 well at the North Oklahoma project has resumed production and oil is now flowing to the tanks. After a period of stabilization of barrel per day (BPD) rates derived from the oil shale production, the Company plans to begin a reservoir engineering assessment by a third party engineer in order to calculate a reserve estimate of barrels of oil in place under the No. 1 well location.
About American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the ?hunt? for domestic petroleum assets. Visit us at: www.americanpetrohunter.com
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of our exploration program at our properties and any anticipated future production. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with petroleum exploration and development stage exploration companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the most recent fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
American Petro-Hunter, Inc.
Robert McIntosh
President & C.E.O.
To find out more about American Petro-Hunter, Inc. (OTCBB: AAPH), visit our website at www.americanpetrohunter.com
Contact:
Mountainview IR Services, Inc.
1-888-521-7762
investors@americanpetrohunterinc.com
Visit the AAPH showcase profile at Investorideas.com
Request News and Info on AAPH
Disclosure, Disclaimer/ AAPH is a paid advertising client on Investorideas.com.
American Petro-hunter Inc. (AAPH.OB) Oct 2010 - one month showcase energy stock on Investorideas.com and energy portals and blogs (three thousand per month)
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
More Investorideas.com Oil and Gas Investor content : http://www.oilandgasstocknews.com/
an energy stocks investor portal within InvestorIdeas.com provides investor research, energy stocks and industry commentary from Karl Miller, stock news and energy links as well as a directory of public companies within the oil and gas sector. Investors can follow energy news by subscribing to the energy stocks newswire at: http://www.investorideas.com/RSS/feeds/Energy.xml
Oil and gas stocks - become a showcase energy stock on www.investorideas.com and its energy portals and blogs for as little as $1000 month !
Sunday, October 17, 2010
Volume Trading Alert: Biomass and Renewable Energy Stocks on the Move; (CRGE: PK), (NYSE:DUK), (NASDAQ:CLNE), (LLEG.PK)
Point Roberts, WA – October 17, 2010 (Investorideas.com Renewable Energy/Green Newswire) - InvestorIdeas.com, a leader in cleantech sector research for investors, reports on recent Biomass and Renewable Energy Stocks news and trading.
Biomass and Renewable Energy Stocks to watch for Monday’s trading include Clenergen Corp. (CRGE.PK), Duke Energy Corporation (NYSE: DUK), Laidlaw Energy Group, Inc. (LLEG.PK), Clean Energy Fuels Corp. (NASDAQ:CLNE)
Green Sector Snapshot: (Trading at time or release on Friday October 15th at close)
Clenergen Corp. (CRGE.PK) trading at $0.8950
Duke Energy Corporation (NYSE: DUK) trading at $17.59, up 0.01 (0.06%)
Laidlaw Energy Group, Inc. (LLEG.PK) trading at $0.0039
Clean Energy Fuels Corp. (NASDAQ:CLNE) trading at $14.79, up 0.37 (2.57%)
Biomass and Renewable Energy Stocks to Watch- News and Company Highlights
Clenergen Corp. (CRGE.PK)
Clenergen Corporation is a publicly-traded renewable energy company within the Biomass sector. Clenergen offers strategic clean energy generation and supply of biomass feedstock to address the requirement for renewable and sustainable supplies of electricity. Clenergen has developed a unique modular system for gasification and localized plantation management. Clenergen also plans to provide biomass feedstock for producing wood pellets for co firing with coal to produce low emission electricity.
Clenergen Corporation intends to use proprietary and mixed biomass feedstock to implement sustainable supplies of clean energy for regional, captive end users, remote islands, and mining companies and, through government- or privately-owned power grid systems, other end users, including private homes. The "Distributed Environmental Power System" marries significant proprietary advancements in plant science with proven long standing engineering technologies to achieve this goal.
Website: www.clenergen.com
Clenergen Corp. (CRGE.PK) Key Highlights
Investing in Clenergen is a partnership in projects addressing the needs of a cleaner greener planet with an environmentally sound and sustainable Clean Energy Generation system, which is in compliance with and in excess of international standards for environmental protection, biodiversity, quality, safety and full traceability backed by a global management team providing a deep wealth of experience in the science, technology, finance and management of this business, as well as practical experiences of managing and investing in similar businesses in both emerging and developed markets.
Significant cash flow generation is provided after the initial build-out phase to adequately service debt; the stability of those cash flows is partially guaranteed through long term, defined, Government provided Power Purchase Agreements (PPA).
Clean Energy (Nasdaq:CLNE ) is the largest provider of natural gas fuel for transportation in North America and a global leader in the expanding natural gas vehicle market. It has operations in CNG and LNG vehicle fueling, construction and operation of CNG and LNG fueling stations, biomethane production, vehicle conversion and compressor technology.
Duke Energy Corporation (NYSE: DUK)
Recent News: “Duke Energy, Integrys Energy Services and Smart Energy Capital today announced the launch of a partnership to build and finance distributed solar projects throughout the United States.
Through the partnership, Duke Energy Generation Services (DEGS) and Integrys Energy Services (Integrys) will focus on jointly owning rooftop and smaller ground-mounted photovoltaic (PV) solar projects that deliver electricity to investment-grade commercial, government and utility customers under long-term power purchase agreements. Smart Energy Capital will develop the projects and arrange financing, enabling DEGS and Integrys to create a streamlined, end-to-end approach to bringing solar projects to market.”
Full Article: http://finance.yahoo.com/news/Duke-Energy-Integrys-Energy-prnews-2045609580.html?x=0&.v=1
Duke Energy Generation Services, part of Duke Energy's Commercial Businesses, is a leader in developing innovative renewable energy solutions, including wind, solar and biopower projects. DEGS builds, owns and operates electric generation for large energy consumers, municipalities, utilities and industrial facilities. DEGS is also working to build commercial transmission capacity to help the U.S. meet its energy needs of the future. Headquartered in Charlotte, N.C., Duke Energy is a Fortune 500 company traded on the New York Stock Exchange under the symbol DUK. More information about the company is available on the Internet at: www.duke-energy.com.
Laidlaw Energy is engaged in the development of independent power plants that generate electricity from renewable resources, with a particular emphasis on biomass power. Laidlaw Energy's mission is to build and manage a profitable portfolio of biomass facilities through the development of new facilities and acquisition of existing facilities, and in so doing become the leading supplier of biomass power in the United States. Laidlaw Energy is headquartered in New York, New York. For more information, please visit our website at www.LaidlawEnergy.com.
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.
About Our Green Investor content:
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Visit www.renewableenergystocks.com or www.investorideas.com/gi
Disclaimer: The following Clenergen Corp news is paid for by third party on behalf of showcase energy stock (fifteen hundred ). Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves possible loss of principal . This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Pink sheet disclaimer: http://www.pinksheets.com/otcguide/investors_protection.jsp
For info on Clenergen Corp. (CRGE.PK) contact the company IR directly.
investor@clenergen.com
For info on Investorideas.com
Contact :
C Van Zant: 800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com
Point Roberts, WA – October 17, 2010 (Investorideas.com Renewable Energy/Green Newswire) - InvestorIdeas.com, a leader in cleantech sector research for investors, reports on recent Biomass and Renewable Energy Stocks news and trading.
Biomass and Renewable Energy Stocks to watch for Monday’s trading include Clenergen Corp. (CRGE.PK), Duke Energy Corporation (NYSE: DUK), Laidlaw Energy Group, Inc. (LLEG.PK), Clean Energy Fuels Corp. (NASDAQ:CLNE)
Green Sector Snapshot: (Trading at time or release on Friday October 15th at close)
Clenergen Corp. (CRGE.PK) trading at $0.8950
Duke Energy Corporation (NYSE: DUK) trading at $17.59, up 0.01 (0.06%)
Laidlaw Energy Group, Inc. (LLEG.PK) trading at $0.0039
Clean Energy Fuels Corp. (NASDAQ:CLNE) trading at $14.79, up 0.37 (2.57%)
Biomass and Renewable Energy Stocks to Watch- News and Company Highlights
Clenergen Corp. (CRGE.PK)
Clenergen Corporation is a publicly-traded renewable energy company within the Biomass sector. Clenergen offers strategic clean energy generation and supply of biomass feedstock to address the requirement for renewable and sustainable supplies of electricity. Clenergen has developed a unique modular system for gasification and localized plantation management. Clenergen also plans to provide biomass feedstock for producing wood pellets for co firing with coal to produce low emission electricity.
Clenergen Corporation intends to use proprietary and mixed biomass feedstock to implement sustainable supplies of clean energy for regional, captive end users, remote islands, and mining companies and, through government- or privately-owned power grid systems, other end users, including private homes. The "Distributed Environmental Power System" marries significant proprietary advancements in plant science with proven long standing engineering technologies to achieve this goal.
Website: www.clenergen.com
Clenergen Corp. (CRGE.PK) Key Highlights
Investing in Clenergen is a partnership in projects addressing the needs of a cleaner greener planet with an environmentally sound and sustainable Clean Energy Generation system, which is in compliance with and in excess of international standards for environmental protection, biodiversity, quality, safety and full traceability backed by a global management team providing a deep wealth of experience in the science, technology, finance and management of this business, as well as practical experiences of managing and investing in similar businesses in both emerging and developed markets.
Significant cash flow generation is provided after the initial build-out phase to adequately service debt; the stability of those cash flows is partially guaranteed through long term, defined, Government provided Power Purchase Agreements (PPA).
Clean Energy (Nasdaq:CLNE ) is the largest provider of natural gas fuel for transportation in North America and a global leader in the expanding natural gas vehicle market. It has operations in CNG and LNG vehicle fueling, construction and operation of CNG and LNG fueling stations, biomethane production, vehicle conversion and compressor technology.
Duke Energy Corporation (NYSE: DUK)
Recent News: “Duke Energy, Integrys Energy Services and Smart Energy Capital today announced the launch of a partnership to build and finance distributed solar projects throughout the United States.
Through the partnership, Duke Energy Generation Services (DEGS) and Integrys Energy Services (Integrys) will focus on jointly owning rooftop and smaller ground-mounted photovoltaic (PV) solar projects that deliver electricity to investment-grade commercial, government and utility customers under long-term power purchase agreements. Smart Energy Capital will develop the projects and arrange financing, enabling DEGS and Integrys to create a streamlined, end-to-end approach to bringing solar projects to market.”
Full Article: http://finance.yahoo.com/news/Duke-Energy-Integrys-Energy-prnews-2045609580.html?x=0&.v=1
Duke Energy Generation Services, part of Duke Energy's Commercial Businesses, is a leader in developing innovative renewable energy solutions, including wind, solar and biopower projects. DEGS builds, owns and operates electric generation for large energy consumers, municipalities, utilities and industrial facilities. DEGS is also working to build commercial transmission capacity to help the U.S. meet its energy needs of the future. Headquartered in Charlotte, N.C., Duke Energy is a Fortune 500 company traded on the New York Stock Exchange under the symbol DUK. More information about the company is available on the Internet at: www.duke-energy.com.
Laidlaw Energy is engaged in the development of independent power plants that generate electricity from renewable resources, with a particular emphasis on biomass power. Laidlaw Energy's mission is to build and manage a profitable portfolio of biomass facilities through the development of new facilities and acquisition of existing facilities, and in so doing become the leading supplier of biomass power in the United States. Laidlaw Energy is headquartered in New York, New York. For more information, please visit our website at www.LaidlawEnergy.com.
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.
About Our Green Investor content:
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Visit www.renewableenergystocks.com or www.investorideas.com/gi
Disclaimer: The following Clenergen Corp news is paid for by third party on behalf of showcase energy stock (fifteen hundred ). Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves possible loss of principal . This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Pink sheet disclaimer: http://www.pinksheets.com/otcguide/investors_protection.jsp
For info on Clenergen Corp. (CRGE.PK) contact the company IR directly.
investor@clenergen.com
For info on Investorideas.com
Contact :
C Van Zant: 800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com
Thursday, October 14, 2010
Investorideas.com - BIOMASS Stocks; Biomass Spotlight Company, Clenergen (CRGE.PK)
Investorideas.com - BIOMASS Stocks; Biomass Spotlight Company, Clenergen (CRGE.PK)
BIOMASS Stocks; Biomass Spotlight Company, Clenergen (CRGE.PK)
October 14, 2010 - Investorideas.com green newswire: Investorideas.com releases the following third party investment report for Biomass Spotlight Company, Clenergen, (CRGE.PK), as prepared by Global Renewable Energy Report, and Hans Thomas.
Investorideas.com is a leader in renewable energy stocks research, featuring news and commentary on solar stocks, wind stocks, biomass stocks and more.
Article by: Global Renewable Energy Report, Hans Thomas
Visit this company: www.insider-picks.com
The single most important investment decision you will ever make... and the Florida based company that holds the secret
My name is Hans Thomas and I'm inviting you to learn about the most interesting renewable energy concept ever introduced, Biomass!
Since 1900, global energy consumption has risen every, single year.
Let me repeat that......Since 1900 global energy consumption has RISEN EVERY SINGLE YEAR.
Energy has been the biggest, best game in town for over a century.
The floor of the New York Stock is filled with children. The floor of the Comex Exchange (energy) is where the big boys play. A wise man once said about the Golden Rule......he who has the gold...buys energy.
The most exclusive energy market in the world just opened its doors to the working guys...you and me:
To understand why this has happened, we first must enter a quaint office in Coconut Creek, Florida, the home of Clenergen Corp. Over the next several months this firm will change the way you make money and if you follow my suggestions carefully, you should be able to realize high double digit growth from this investment.
In this office lies a secret which will revolutionize the way the Biomass industry has operated for years.
This article is being written to tell you that the concepts forming at Clenergen and other industry leaders changes everything.
Yes, Everything!
The cost of everything, from transportation to real estate depends on knowing with the price of energy is in the near term future.
If you knew the price of energy in the near future you would control the market, but you don't. However, if I told you that knowing the price of energy is really more about understanding what the price of inputs are combined with the selling price of the output.
Companies throughout the energy industry are signing long term power purchase agreements to accomplish long term revenue goals...all without knowing the price of the input. This is a decades old practice and is foolish!
Have you ever heard of your local utility having to go back to the state's energy board and ask for a rate increase because “summer temperatures were unseasonably hot”? They knew what the outputs were, but miscalculated the inputs.
Throw out your time tested strategies, plans and hedges as the short term rotation crop location concept will open your eyes and will make you understand that companies like Clenergen are our energy future.
I have been right 86.7% for the past 13 years, a solid track record in selecting equities. This tiny piece of information on renewable energy has altered forever the direction of my life, has made me wealthy and made countless others wealthier.
I want to offer to you this compelling story click here to go to www.insider-picks.com/crge
Read This Carefully
The renewable energy market has gone global and firms like Clenergen Corp (CRGE) and Southern Company (SO) are leading the charge. As a result and if you act quickly the profit-opportunity of a lifetime awaits you.
Act Now!
On the very day Clenergen Corp fired up operations on their Biomass facility in Tamil Nandu, India, a coal fired plant in the same country was shuttered due to a lack of available feedstock. A hastily organized meeting by the United States department of Energy was called to ensure that US energy plants are not threatened by the same outcome; as the US energy network is dependent upon global production.
So from Tamil Nandu, India across the Russian tundra, through the Alaskan pipeline, over the rocky mountains and down to Costa Rica, one, seamless network running to and from provides the power the global energy market demands.
The result of short rotation crops being located at or near generation stations is changing an entire industry. In the beginning everyone tries to understand the concept, prices dip and finally a total shakeup of the energy equation, as traditional methods and solar, wind, nuclear, biomass and wind power are re-evaluated, re-priced and radically reorganized.
As the suits in Washington continue to create stricter rules on reducing the carbon footprint, renewable come to the surface and put a strain on traditional utilities.
Without a doubt the game has changed.
My prediction that Clenergen would increase in price over 100% in 3 months was wrong, instead it took just 2 weeks.
September 25, 2010 $.49 - October 10, 2010 $1.13
Most investors will be late to the show and will not make the huge returns, will likely talk about how close they were to landing the big fish and lose out.
But if you subscribe now the Global Renewable Energy Report, you will consistently be provided the most current information on the trends in the industry and can stay well ahead of the market. They will understand how and when to enter and exit a position to benefit substantially from renewable energy trades.
As a subscriber, you will have the opportunity to triple your money
And here's the thing:
The Race is already underway...
..since Clenergen, among others have promoted projects totaling 1000s of mw/H in the Biomass sector.
And participation in this opportunity is available to you today.
But, The Prospect Is Even Better as the Windfall Lies with the Smaller Companies
Huge profits in the months ahead are reserved for smaller companies that can control costs.
It is all absolutely FREE and available with a simple click. www.insider-picks.com/crge
Big energy companies are in trouble
In the showdown between Biomass and coal, BIOMASS is the big winner in Washington's new legislation on carbon emissions.
Clenergen is in the forefront and should capture huge profits in the near term.
Why electricity is the lead form of energy delivery and use.
Why countries like India and the Philippines are dominant in the Biomass industry and what has changed the outlook for the United States. Don't miss this!
My goal for you is simple....to provide you with enough information to make you wealthy, REALLY WEALTHY. I have enjoyed successes well beyond my imagination all from analysis of good information. I have had the opportunity to eat lunch with gentlemen like Dan Devos and Herb Brooks, partnered with NFL football and NBA basketball players and currently am advising the Omani government on restructuring their oil distribution portfolio to prepare for a surge in renewable generation.
As the price of energy stocks fluctuates, information from the report will allow you to identify divergences between energy stocks and when to enter and exit positions. I talk about trading strategies and feature a renewable energy company each and every issue.
I think you will agree the Global Renewable Energy Report is a necessity when making stock selections.
Take care for now!
Hans Thomas
The following report is prepared by Global Renewable Energy Report and is not the opinion of Investorideas.com Investorideas.com is a leader in cleantech investor research. Learn more about green investing at http://www.investorideas.com/gi
Disclaimer /disclosure: The following news is paid for and /or published as information only for our readers. The info on CRGE.PK is a paid for submission paid for by a third party (fifteen hundred for one week of news /articles). Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investments involve risk and possible loss of principal. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Pink sheet disclaimer: http://www.pinksheets.com/otcguide/investors_protection.jsp
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
News and Stories Published at www.investorideas.com Clean Energy Stocks Blog for Green Investors: Research Renewable Energy and water stocks as an Investor Ideas member and gain access to global green stock directories. Become an Investorideas.com member and research stocks and invest in cleantech : get login access to all 4 cleantech stock directories including water stocks and renewable energy stocks : http://www.investorideas.com/membership
/
.Disclaimer: this is not a solicitation to buy or sell stocks, or an endorsement for any company.Cleantech green stocks - become a showcase green stock at www.investorideas.com - a leader in cleantech investor research for as little as $1000 month.
BIOMASS Stocks; Biomass Spotlight Company, Clenergen (CRGE.PK)
October 14, 2010 - Investorideas.com green newswire: Investorideas.com releases the following third party investment report for Biomass Spotlight Company, Clenergen, (CRGE.PK), as prepared by Global Renewable Energy Report, and Hans Thomas.
Investorideas.com is a leader in renewable energy stocks research, featuring news and commentary on solar stocks, wind stocks, biomass stocks and more.
Article by: Global Renewable Energy Report, Hans Thomas
Visit this company: www.insider-picks.com
The single most important investment decision you will ever make... and the Florida based company that holds the secret
My name is Hans Thomas and I'm inviting you to learn about the most interesting renewable energy concept ever introduced, Biomass!
Since 1900, global energy consumption has risen every, single year.
Let me repeat that......Since 1900 global energy consumption has RISEN EVERY SINGLE YEAR.
Energy has been the biggest, best game in town for over a century.
The floor of the New York Stock is filled with children. The floor of the Comex Exchange (energy) is where the big boys play. A wise man once said about the Golden Rule......he who has the gold...buys energy.
The most exclusive energy market in the world just opened its doors to the working guys...you and me:
To understand why this has happened, we first must enter a quaint office in Coconut Creek, Florida, the home of Clenergen Corp. Over the next several months this firm will change the way you make money and if you follow my suggestions carefully, you should be able to realize high double digit growth from this investment.
In this office lies a secret which will revolutionize the way the Biomass industry has operated for years.
This article is being written to tell you that the concepts forming at Clenergen and other industry leaders changes everything.
Yes, Everything!
The cost of everything, from transportation to real estate depends on knowing with the price of energy is in the near term future.
If you knew the price of energy in the near future you would control the market, but you don't. However, if I told you that knowing the price of energy is really more about understanding what the price of inputs are combined with the selling price of the output.
Companies throughout the energy industry are signing long term power purchase agreements to accomplish long term revenue goals...all without knowing the price of the input. This is a decades old practice and is foolish!
Have you ever heard of your local utility having to go back to the state's energy board and ask for a rate increase because “summer temperatures were unseasonably hot”? They knew what the outputs were, but miscalculated the inputs.
Throw out your time tested strategies, plans and hedges as the short term rotation crop location concept will open your eyes and will make you understand that companies like Clenergen are our energy future.
I have been right 86.7% for the past 13 years, a solid track record in selecting equities. This tiny piece of information on renewable energy has altered forever the direction of my life, has made me wealthy and made countless others wealthier.
I want to offer to you this compelling story click here to go to www.insider-picks.com/crge
Read This Carefully
The renewable energy market has gone global and firms like Clenergen Corp (CRGE) and Southern Company (SO) are leading the charge. As a result and if you act quickly the profit-opportunity of a lifetime awaits you.
Act Now!
On the very day Clenergen Corp fired up operations on their Biomass facility in Tamil Nandu, India, a coal fired plant in the same country was shuttered due to a lack of available feedstock. A hastily organized meeting by the United States department of Energy was called to ensure that US energy plants are not threatened by the same outcome; as the US energy network is dependent upon global production.
So from Tamil Nandu, India across the Russian tundra, through the Alaskan pipeline, over the rocky mountains and down to Costa Rica, one, seamless network running to and from provides the power the global energy market demands.
The result of short rotation crops being located at or near generation stations is changing an entire industry. In the beginning everyone tries to understand the concept, prices dip and finally a total shakeup of the energy equation, as traditional methods and solar, wind, nuclear, biomass and wind power are re-evaluated, re-priced and radically reorganized.
As the suits in Washington continue to create stricter rules on reducing the carbon footprint, renewable come to the surface and put a strain on traditional utilities.
Without a doubt the game has changed.
My prediction that Clenergen would increase in price over 100% in 3 months was wrong, instead it took just 2 weeks.
September 25, 2010 $.49 - October 10, 2010 $1.13
Most investors will be late to the show and will not make the huge returns, will likely talk about how close they were to landing the big fish and lose out.
But if you subscribe now the Global Renewable Energy Report, you will consistently be provided the most current information on the trends in the industry and can stay well ahead of the market. They will understand how and when to enter and exit a position to benefit substantially from renewable energy trades.
As a subscriber, you will have the opportunity to triple your money
And here's the thing:
The Race is already underway...
..since Clenergen, among others have promoted projects totaling 1000s of mw/H in the Biomass sector.
And participation in this opportunity is available to you today.
But, The Prospect Is Even Better as the Windfall Lies with the Smaller Companies
Huge profits in the months ahead are reserved for smaller companies that can control costs.
It is all absolutely FREE and available with a simple click. www.insider-picks.com/crge
Big energy companies are in trouble
In the showdown between Biomass and coal, BIOMASS is the big winner in Washington's new legislation on carbon emissions.
Clenergen is in the forefront and should capture huge profits in the near term.
Why electricity is the lead form of energy delivery and use.
Why countries like India and the Philippines are dominant in the Biomass industry and what has changed the outlook for the United States. Don't miss this!
My goal for you is simple....to provide you with enough information to make you wealthy, REALLY WEALTHY. I have enjoyed successes well beyond my imagination all from analysis of good information. I have had the opportunity to eat lunch with gentlemen like Dan Devos and Herb Brooks, partnered with NFL football and NBA basketball players and currently am advising the Omani government on restructuring their oil distribution portfolio to prepare for a surge in renewable generation.
As the price of energy stocks fluctuates, information from the report will allow you to identify divergences between energy stocks and when to enter and exit positions. I talk about trading strategies and feature a renewable energy company each and every issue.
I think you will agree the Global Renewable Energy Report is a necessity when making stock selections.
Take care for now!
Hans Thomas
The following report is prepared by Global Renewable Energy Report and is not the opinion of Investorideas.com Investorideas.com is a leader in cleantech investor research. Learn more about green investing at http://www.investorideas.com/gi
Disclaimer /disclosure: The following news is paid for and /or published as information only for our readers. The info on CRGE.PK is a paid for submission paid for by a third party (fifteen hundred for one week of news /articles). Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investments involve risk and possible loss of principal. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Pink sheet disclaimer: http://www.pinksheets.com/otcguide/investors_protection.jsp
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
News and Stories Published at www.investorideas.com Clean Energy Stocks Blog for Green Investors: Research Renewable Energy and water stocks as an Investor Ideas member and gain access to global green stock directories. Become an Investorideas.com member and research stocks and invest in cleantech : get login access to all 4 cleantech stock directories including water stocks and renewable energy stocks : http://www.investorideas.com/membership
/
.Disclaimer: this is not a solicitation to buy or sell stocks, or an endorsement for any company.Cleantech green stocks - become a showcase green stock at www.investorideas.com - a leader in cleantech investor research for as little as $1000 month.
Sunday, October 10, 2010
Oil and Gas Stocks Sector Close-Up; Trading for (OTCBB: AAPH), (OTCQB: USOG), (NYSE:CVX), (NYSE:NOV)
Point Roberts, WA – October 10, 2010 (Investorideas.com Energy Newswire) - InvestorIdeas.com, leader in sector research for investors, reports on Oil and Gas Stocks news and trading for Friday’s close for energy investors.
Oil and Gas Stocks include American Petro-hunter Inc (OTCBB: AAPH), United States Oil & Gas Corp (OTCQB: USOG), Chevron Corp (NYSE:CVX), and National Oilwell Varco, Inc (NYSE:NOV)
Sector Snapshot: (as of close Oct 8th)
American Petro-hunter Inc (OTCBB: AAPH) trading at $0.32
United States Oil & Gas Corp (OTCQB: USOG) trading at $0.0021 - 0.0026 on over 19 million
Chevron Corp (NYSE:CVX), trading at $83.94, up 0.42 (0.50%)
National Oilwell Varco, Inc (NYSE:NOV) trading at 46.61, up 0.97 (2.13%)
Market Snapshot:
Crude Oil Nov 10 83.13 +0.47 Crude Oil Nov 10
Gold Oct 10 1,346.70 +3.80 Gold Oct 10
Natural Gas Nov 10 3.64 -0.01 Natural Gas Nov 10
RBOB Gasoline Nov 10 2.16 +0.01
Oil and Gas Stocks to Watch News
American Petro-hunter Inc (OTCBB: AAPH) Key Highlights and Recent Press
Latest News: October 4th
American Petro-Hunter Prepares NOJ26 for Commercial Oil Production at North Oklahoma Project
“American Petro-Hunter, Inc. is pleased to advise that the previously announced plans for completion of the NOJ26 well at the North Oklahoma Oil Project have commenced. Operations are now underway in order to prepare the well for commercial production. This includes the purchase of a pumping unit and tank battery which are currently undergoing installation at the well site.
Based on an assessment of the well and analysis of the oil shows, the partners have concluded to commence the completion program by first addressing the lower of the two 40 foot pay zones. The oil shale will be perforated, acidized and subsequently put on pump. The completion efforts will culminate in swab and flow testing of the oil bearing shale formation to determine what the zone can and will deliver on a BPD (barrel per day) basis. The Company is confident that based on strong oil shows and subject to fracture stimulation in the shale, the lower pay zone will produce at rates in excess of the No. 1 well which tested at 80 BPD under similar conditions. The upper pay zone directly above the shale at NOJ26 exhibited excellent oil shows and log responses and will be put into production following a period of evaluation in order to maximize the response from the shale..”
American Petro-hunter Inc. is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the "hunt" for domestic petroleum assets.
Full news: http://finance.yahoo.com/news/American-PetroHunter-Prepares-iw-3195731505.html?x=0&.v=1
Website: www.aaphreport.com
Visit the AAPH showcase profile on Investorideas.com to learn more:
http://www.investorideas.com/CO/AAPH/
American Petro-Hunter Inc., Key Highlights
-AAPH has acquired working interests in quality oil and gas projects currently focusing on gas in California and oil in Kansas
-AAPH has drilled a successful commercial well on its first endeavor in Kansas.
-AAPH has aligned itself with prudent, experienced and effective oil and gas professionals as project operators.
-AAPH bases its acquisitions on a mix of acceptable risk, high reward and short payback in historically successful and productive regions.
-AAPH plans to "grow by the drill bit" in "our back yard" as we believe the US Domestic oil and gas market will continue to grow in the face of alternative energy which is deemed to be years from maturity.
-AAPH has the stated aim of becoming a 500 BOE producer within 18 months.
-AAPH plans to invest in projects with manageable participation expenditures so as to minimize share dilution.
-AAPH strives to build stakeholder value by prudent management that integrates a "shareholder first" philosophy.
-AAPH will be open, honest and transparent on all projects so as to ensure stakeholders receive accurate, up-to-date project information on a consistent basis
-AAPH will be a good corporate citizen, ensuring our operations meet or exceed all regulatory standards for the environment
-AAPH plans to continue the "hunt for petroleum" as it believes the answer to our reliance on foreign energy is "right next door."
United States Oil & Gas Corp (OTCQB: USOG)
Recent News: “United States Oil and Gas Corp is pleased to announce that as a result of its registration statement with the SEC becoming effective and remaining current in its required filings, its common shares are now trading on the OTC market for U.S. registered companies. The Company's ticker symbol, USOG, remains the same.”
Full Article: http://finance.yahoo.com/news/United-States-Oil-and-Gas-iw-3489930450.html?x=0&.v=1
About United States Oil & Gas Corp (OTCQB: USOG): United States Oil and Gas Corp is focused on acquiring and growing domestic oil and gas services companies. We target mid size family-run businesses with historically profitable results, strong balance sheets, high profit margins, and solid management teams in place. Our subsidiary, Turnbull, which had revenues of $14 million in 2009, was founded in 1965. We own all of the facilities and equipment used at our locations in Plainville, Utica, and Palco, Kansas. Our subsidiary, United, was founded in 2003, and sells and distributes refined oil and gas products including specialty racing fuels throughout North Dakota as well as regions of South Dakota and Montana. We own and operate a convenience store in Belcourt, and hold approximately six acres of developable land located in Bottineau, North Dakota.
Chevron Corp (NYSE:CVX)
About Chevron Corp (NYSE:CVX): Chevron is one of the world’s leading integrated energy companies, with subsidiaries that conduct business worldwide. The company’s success is driven by the ingenuity and commitment of its employees and their application of the most innovative technologies in the world. Chevron is involved in virtually every facet of the energy industry. The company explores for, produces and transports crude oil and natural gas; refines, markets and distributes transportation fuels and other energy products; manufactures and sells petrochemical products; generates power and produces geothermal energy; provides energy efficiency solutions; and develops the energy resources of the future; including bio-fuels. Chevron is based in San Ramon, Calif. More information about Chevron is available at www.chevron.com.
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.
About our Oil and Gas portal:
http://www.oilandgasstocksnews.com/ is a global meeting place for investors and industry following the energy sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our oil and gas and natural gas stock directories.
Disclaimer: The following American Petro-Hunter Inc news is paid for by third party on behalf of showcase energy stock AAPH (three thousand per month). Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
For info on American Petro-hunter Inc (OTCBB: AAPH) contact the company IR directly.
For info on Investorideas.com
Contact:
C Van Zant: 800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com
Point Roberts, WA – October 10, 2010 (Investorideas.com Energy Newswire) - InvestorIdeas.com, leader in sector research for investors, reports on Oil and Gas Stocks news and trading for Friday’s close for energy investors.
Oil and Gas Stocks include American Petro-hunter Inc (OTCBB: AAPH), United States Oil & Gas Corp (OTCQB: USOG), Chevron Corp (NYSE:CVX), and National Oilwell Varco, Inc (NYSE:NOV)
Sector Snapshot: (as of close Oct 8th)
American Petro-hunter Inc (OTCBB: AAPH) trading at $0.32
United States Oil & Gas Corp (OTCQB: USOG) trading at $0.0021 - 0.0026 on over 19 million
Chevron Corp (NYSE:CVX), trading at $83.94, up 0.42 (0.50%)
National Oilwell Varco, Inc (NYSE:NOV) trading at 46.61, up 0.97 (2.13%)
Market Snapshot:
Crude Oil Nov 10 83.13 +0.47 Crude Oil Nov 10
Gold Oct 10 1,346.70 +3.80 Gold Oct 10
Natural Gas Nov 10 3.64 -0.01 Natural Gas Nov 10
RBOB Gasoline Nov 10 2.16 +0.01
Oil and Gas Stocks to Watch News
American Petro-hunter Inc (OTCBB: AAPH) Key Highlights and Recent Press
Latest News: October 4th
American Petro-Hunter Prepares NOJ26 for Commercial Oil Production at North Oklahoma Project
“American Petro-Hunter, Inc. is pleased to advise that the previously announced plans for completion of the NOJ26 well at the North Oklahoma Oil Project have commenced. Operations are now underway in order to prepare the well for commercial production. This includes the purchase of a pumping unit and tank battery which are currently undergoing installation at the well site.
Based on an assessment of the well and analysis of the oil shows, the partners have concluded to commence the completion program by first addressing the lower of the two 40 foot pay zones. The oil shale will be perforated, acidized and subsequently put on pump. The completion efforts will culminate in swab and flow testing of the oil bearing shale formation to determine what the zone can and will deliver on a BPD (barrel per day) basis. The Company is confident that based on strong oil shows and subject to fracture stimulation in the shale, the lower pay zone will produce at rates in excess of the No. 1 well which tested at 80 BPD under similar conditions. The upper pay zone directly above the shale at NOJ26 exhibited excellent oil shows and log responses and will be put into production following a period of evaluation in order to maximize the response from the shale..”
American Petro-hunter Inc. is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the "hunt" for domestic petroleum assets.
Full news: http://finance.yahoo.com/news/American-PetroHunter-Prepares-iw-3195731505.html?x=0&.v=1
Website: www.aaphreport.com
Visit the AAPH showcase profile on Investorideas.com to learn more:
http://www.investorideas.com/CO/AAPH/
American Petro-Hunter Inc., Key Highlights
-AAPH has acquired working interests in quality oil and gas projects currently focusing on gas in California and oil in Kansas
-AAPH has drilled a successful commercial well on its first endeavor in Kansas.
-AAPH has aligned itself with prudent, experienced and effective oil and gas professionals as project operators.
-AAPH bases its acquisitions on a mix of acceptable risk, high reward and short payback in historically successful and productive regions.
-AAPH plans to "grow by the drill bit" in "our back yard" as we believe the US Domestic oil and gas market will continue to grow in the face of alternative energy which is deemed to be years from maturity.
-AAPH has the stated aim of becoming a 500 BOE producer within 18 months.
-AAPH plans to invest in projects with manageable participation expenditures so as to minimize share dilution.
-AAPH strives to build stakeholder value by prudent management that integrates a "shareholder first" philosophy.
-AAPH will be open, honest and transparent on all projects so as to ensure stakeholders receive accurate, up-to-date project information on a consistent basis
-AAPH will be a good corporate citizen, ensuring our operations meet or exceed all regulatory standards for the environment
-AAPH plans to continue the "hunt for petroleum" as it believes the answer to our reliance on foreign energy is "right next door."
United States Oil & Gas Corp (OTCQB: USOG)
Recent News: “United States Oil and Gas Corp is pleased to announce that as a result of its registration statement with the SEC becoming effective and remaining current in its required filings, its common shares are now trading on the OTC market for U.S. registered companies. The Company's ticker symbol, USOG, remains the same.”
Full Article: http://finance.yahoo.com/news/United-States-Oil-and-Gas-iw-3489930450.html?x=0&.v=1
About United States Oil & Gas Corp (OTCQB: USOG): United States Oil and Gas Corp is focused on acquiring and growing domestic oil and gas services companies. We target mid size family-run businesses with historically profitable results, strong balance sheets, high profit margins, and solid management teams in place. Our subsidiary, Turnbull, which had revenues of $14 million in 2009, was founded in 1965. We own all of the facilities and equipment used at our locations in Plainville, Utica, and Palco, Kansas. Our subsidiary, United, was founded in 2003, and sells and distributes refined oil and gas products including specialty racing fuels throughout North Dakota as well as regions of South Dakota and Montana. We own and operate a convenience store in Belcourt, and hold approximately six acres of developable land located in Bottineau, North Dakota.
Chevron Corp (NYSE:CVX)
About Chevron Corp (NYSE:CVX): Chevron is one of the world’s leading integrated energy companies, with subsidiaries that conduct business worldwide. The company’s success is driven by the ingenuity and commitment of its employees and their application of the most innovative technologies in the world. Chevron is involved in virtually every facet of the energy industry. The company explores for, produces and transports crude oil and natural gas; refines, markets and distributes transportation fuels and other energy products; manufactures and sells petrochemical products; generates power and produces geothermal energy; provides energy efficiency solutions; and develops the energy resources of the future; including bio-fuels. Chevron is based in San Ramon, Calif. More information about Chevron is available at www.chevron.com.
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.
About our Oil and Gas portal:
http://www.oilandgasstocksnews.com/ is a global meeting place for investors and industry following the energy sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our oil and gas and natural gas stock directories.
Disclaimer: The following American Petro-Hunter Inc news is paid for by third party on behalf of showcase energy stock AAPH (three thousand per month). Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
For info on American Petro-hunter Inc (OTCBB: AAPH) contact the company IR directly.
For info on Investorideas.com
Contact:
C Van Zant: 800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com
Thursday, September 30, 2010
Today's Nanotechnology stock news from http://www.investorideas.com/
Investorideas.com updates its Nanotechnology investors for September 30th
Nanotechnology Stocks; mPhase (OTC.BB:XDSL) Smart NanoBattery Featured in September 2010 Issue of Medical Products Manufacturing News
mPhase has sights on Medical Applications
Read today's news on Nanotechnology stocks: http://www.investorideas.com/CO/XDSL/news/9301.asp
Want to research Nanotech stocks? Visit our Nanotechnology stocks portal
http://www.nanotechnologyinvestment.com/ and our nanotech stocks directory
We have some of the most comprehensive stock directories online. Also subscribe to our free news feeds.
Get stock alerts on our showcase stocks - see our latest companies
http://www.investorideas.com/Resources/Newsletter.asp
The team at Investorideas.com - - Investor Ideas that can Change the World
Investorideas.com updates its Nanotechnology investors for September 30th
Nanotechnology Stocks; mPhase (OTC.BB:XDSL) Smart NanoBattery Featured in September 2010 Issue of Medical Products Manufacturing News
mPhase has sights on Medical Applications
Read today's news on Nanotechnology stocks: http://www.investorideas.com/CO/XDSL/news/9301.asp
Want to research Nanotech stocks? Visit our Nanotechnology stocks portal
http://www.nanotechnologyinvestment.com/ and our nanotech stocks directory
We have some of the most comprehensive stock directories online. Also subscribe to our free news feeds.
Get stock alerts on our showcase stocks - see our latest companies
http://www.investorideas.com/Resources/Newsletter.asp
The team at Investorideas.com - - Investor Ideas that can Change the World
Monday, September 27, 2010
Investorideas.com - Biotech Stocks on the Move: High Volume Traders; (OTCBB: UVFT), (OTCBB: KBLB), (NASDAQ:SGEN), (NASDAQ:GENZ)
Investorideas.com - Biotech Stocks on the Move: High Volume Traders; (OTCBB: UVFT), (OTCBB: KBLB), (NASDAQ:SGEN), (NASDAQ:GENZ)
Visit this company: www.uvflutech.com
Point Roberts, WA - September 27, 2010 (Investorideas.com Newswire, www.biotechindustrystocks.com) - InvestorIdeas.com, a leader in sector research for investors, reports on recent Volume Leading Biotech/ Pharma Stocks news and trading for September 27th on the OTCBB and NASDAQ Markets. Top gainers included Seattle Genetics, Inc. (NASDAQ: SGEN), one of the most advanced stocks on the Nasdaq.com in morning trading.
(
Biotech Stocks include UV Flu Technologies, Inc., (OTCBB: UVFT), Seattle Genetics Inc (NASDAQ:SGEN), Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB), and Genzyme Corp. (NASDAQ:GENZ)
Sector Snapshot: (Trading at time or release)
UV Flu Technologies, Inc., (OTCBB: UVFT) trading at $ 0.34, up 0.02 (6.25%)
Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB), trading at $ 0. 2410, up 0.0229 (10.04%) on Volume of 13,387,394 shares
Seattle Genetics Inc. (NASDAQ: SGEN), trading at $14.91, up 2.75 (22.62%) on Volume of 7,333,439 shares
Genzyme Corp. (NASDAQ:GENZ) trading at $ 71.75, up 0.15 (0.21%)
Biotech Stocks to Watch; Recent News
UV Flu Technologies, Inc., (OTCBB: UVFT) Key Highlights and Recent Press
UV Flu Technologies, Inc., (OTCBB: UVFT) is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector. The Company manufactures the VIRATECH UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. UV Flu is committed to providing clean air to improve health and prevent the spread of disease.
The company recently announced that in response to recent outbreaks of drug resistant superbugs such as NDM-1, and persistent occurrences of highly contagious strains of bacteria such as MRSA, the Company is implementing a national campaign to inform the public how its ViraTech UV-400 indoor air purifier significantly helps reduce exposure risks.
UV Flu Technologies, Inc., Key Highlights
FDA Approved as a Class II Medical device
Extensive testing by EPA and FDA certified laboratories confirm the proprietary system has over 99% effectiveness of eliminating bacteria
The Company's strategic differentiators include excellent independent test results proving the effectiveness and safety of its products, proprietary design, and FDA market clearance approving the sale of its products as medical devices.
The Company has been issued U.S. Patent No. 6939397 with 43 claims covering its innovative removable cartridge, housing, UV chamber, UV radiation source and baffle technology.
UV Flu's products are environmentally friendly. The energy efficient system does not use or produce ozone, uses less energy than a 100 watt light bulb and can qualify for Green Building programs.
Experts have warned that a new type of drug-resistant superbug is emerging. NDM-1 is a gene carried by bacteria that makes the strain resistant to some of the most powerful antibiotics. NDM-1 can easily now jump from one strain of bacteria to another.
Latest News:
"UV Flu Technologies, Inc. (OTCBB: UVFT) (the "Company") is pleased to announce that the company and its flagship UV-400 air purification system will be featured on a segment of the “Designing Spaces” TV Show, to be aired nationally during the 4th quarter. The show, to be aired on the Women’s Entertainment channel, is scheduled for the holiday season and is expected to reach up to 75 million households."
Full Article: http://finance.yahoo.com/news/UV-Flu-Technologies-to-Be-iw-1288158894.html?x=0&.v=1
Website: http://www.uvflutech.com/
Seattle Genetics Inc (NASDAQ:SGEN)
Seattle Genetics Inc (NASDAQ:SGEN) Recent News: “Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502 - News), today announced positive top-line results from the pivotal trial of single-agent brentuximab vedotin (SGN-35), an antibody-drug conjugate (ADC) targeted to CD30. The trial was conducted in 102 relapsed or refractory Hodgkin lymphoma (HL) patients.
Seventy-five percent of patients in the pivotal trial achieved an objective response as assessed by an independent central review, the primary endpoint of the trial. The median duration of response was greater than six months. The safety profile of brentuximab vedotin in this trial was generally consistent with prior clinical trial experience. A more complete data set will be presented at an upcoming scientific meeting."
Full News http://www.investorideas.com/news/9273.asp
About Seattle Genetics Inc (NASDAQ:SGEN):
Seattle Genetics is a clinical-stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. The company’s lead product candidate, brentuximab vedotin, is being evaluated in a variety of lymphoma treatment settings including the relapsed and refractory Hodgkin lymphoma indication for which top-line pivotal data have been reported. In addition, Seattle Genetics has four other clinical-stage programs: SGN-75, ASG-5ME, dacetuzumab (SGN-40) and SGN-70. Seattle Genetics has collaborations for its ADC technology with a number of leading biotechnology and pharmaceutical companies, including Bayer, Celldex Therapeutics, Daiichi Sankyo, Genentech, GlaxoSmithKline, MedImmune, a subsidiary of AstraZeneca, Millennium: The Takeda Oncology Company and Progenics, as well as ADC co-development agreements with Agensys, an affiliate of Astellas, and Genmab. More information can be found at www.seattlegenetics.com.
Market Snapshot: (at time of release)
Dow 10,832.48 -27.78 -0.26% Nasdaq 2,372.96 -8.26 -0.35% S&P 500 1,144.53 -4.14 -0.36% 10 Yr Bond (%) 2.5300% -0.8200 Oil 75.68 -0.81 -1.06% Gold 1,297.00 +1.00 +0.08%
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About our Biotech investor portal:
BiotechIndustryStocks.com Portal is a global meeting place for investors and industry following the sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our stock directories.
Disclaimer: The following news is paid for by third party on behalf of UV Flu Technologies, Inc., (eight hundred) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
C Van Zant: 800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com
More Investorideas Biotech Stocks info wwww.BiotechIndustryStocks.com - A Leading Global Investor Website for Biotech Industry Stocks, Biotech, Pharma and Industry News and Biotech Investor Research Tools including a Biotech Stocks Directory
Visit this company: www.uvflutech.com
Point Roberts, WA - September 27, 2010 (Investorideas.com Newswire, www.biotechindustrystocks.com) - InvestorIdeas.com, a leader in sector research for investors, reports on recent Volume Leading Biotech/ Pharma Stocks news and trading for September 27th on the OTCBB and NASDAQ Markets. Top gainers included Seattle Genetics, Inc. (NASDAQ: SGEN), one of the most advanced stocks on the Nasdaq.com in morning trading.
(
Biotech Stocks include UV Flu Technologies, Inc., (OTCBB: UVFT), Seattle Genetics Inc (NASDAQ:SGEN), Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB), and Genzyme Corp. (NASDAQ:GENZ)
Sector Snapshot: (Trading at time or release)
UV Flu Technologies, Inc., (OTCBB: UVFT) trading at $ 0.34, up 0.02 (6.25%)
Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB), trading at $ 0. 2410, up 0.0229 (10.04%) on Volume of 13,387,394 shares
Seattle Genetics Inc. (NASDAQ: SGEN), trading at $14.91, up 2.75 (22.62%) on Volume of 7,333,439 shares
Genzyme Corp. (NASDAQ:GENZ) trading at $ 71.75, up 0.15 (0.21%)
Biotech Stocks to Watch; Recent News
UV Flu Technologies, Inc., (OTCBB: UVFT) Key Highlights and Recent Press
UV Flu Technologies, Inc., (OTCBB: UVFT) is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector. The Company manufactures the VIRATECH UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. UV Flu is committed to providing clean air to improve health and prevent the spread of disease.
The company recently announced that in response to recent outbreaks of drug resistant superbugs such as NDM-1, and persistent occurrences of highly contagious strains of bacteria such as MRSA, the Company is implementing a national campaign to inform the public how its ViraTech UV-400 indoor air purifier significantly helps reduce exposure risks.
UV Flu Technologies, Inc., Key Highlights
FDA Approved as a Class II Medical device
Extensive testing by EPA and FDA certified laboratories confirm the proprietary system has over 99% effectiveness of eliminating bacteria
The Company's strategic differentiators include excellent independent test results proving the effectiveness and safety of its products, proprietary design, and FDA market clearance approving the sale of its products as medical devices.
The Company has been issued U.S. Patent No. 6939397 with 43 claims covering its innovative removable cartridge, housing, UV chamber, UV radiation source and baffle technology.
UV Flu's products are environmentally friendly. The energy efficient system does not use or produce ozone, uses less energy than a 100 watt light bulb and can qualify for Green Building programs.
Experts have warned that a new type of drug-resistant superbug is emerging. NDM-1 is a gene carried by bacteria that makes the strain resistant to some of the most powerful antibiotics. NDM-1 can easily now jump from one strain of bacteria to another.
Latest News:
"UV Flu Technologies, Inc. (OTCBB: UVFT) (the "Company") is pleased to announce that the company and its flagship UV-400 air purification system will be featured on a segment of the “Designing Spaces” TV Show, to be aired nationally during the 4th quarter. The show, to be aired on the Women’s Entertainment channel, is scheduled for the holiday season and is expected to reach up to 75 million households."
Full Article: http://finance.yahoo.com/news/UV-Flu-Technologies-to-Be-iw-1288158894.html?x=0&.v=1
Website: http://www.uvflutech.com/
Seattle Genetics Inc (NASDAQ:SGEN)
Seattle Genetics Inc (NASDAQ:SGEN) Recent News: “Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502 - News), today announced positive top-line results from the pivotal trial of single-agent brentuximab vedotin (SGN-35), an antibody-drug conjugate (ADC) targeted to CD30. The trial was conducted in 102 relapsed or refractory Hodgkin lymphoma (HL) patients.
Seventy-five percent of patients in the pivotal trial achieved an objective response as assessed by an independent central review, the primary endpoint of the trial. The median duration of response was greater than six months. The safety profile of brentuximab vedotin in this trial was generally consistent with prior clinical trial experience. A more complete data set will be presented at an upcoming scientific meeting."
Full News http://www.investorideas.com/news/9273.asp
About Seattle Genetics Inc (NASDAQ:SGEN):
Seattle Genetics is a clinical-stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. The company’s lead product candidate, brentuximab vedotin, is being evaluated in a variety of lymphoma treatment settings including the relapsed and refractory Hodgkin lymphoma indication for which top-line pivotal data have been reported. In addition, Seattle Genetics has four other clinical-stage programs: SGN-75, ASG-5ME, dacetuzumab (SGN-40) and SGN-70. Seattle Genetics has collaborations for its ADC technology with a number of leading biotechnology and pharmaceutical companies, including Bayer, Celldex Therapeutics, Daiichi Sankyo, Genentech, GlaxoSmithKline, MedImmune, a subsidiary of AstraZeneca, Millennium: The Takeda Oncology Company and Progenics, as well as ADC co-development agreements with Agensys, an affiliate of Astellas, and Genmab. More information can be found at www.seattlegenetics.com.
Market Snapshot: (at time of release)
Dow 10,832.48 -27.78 -0.26% Nasdaq 2,372.96 -8.26 -0.35% S&P 500 1,144.53 -4.14 -0.36% 10 Yr Bond (%) 2.5300% -0.8200 Oil 75.68 -0.81 -1.06% Gold 1,297.00 +1.00 +0.08%
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About our Biotech investor portal:
BiotechIndustryStocks.com Portal is a global meeting place for investors and industry following the sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our stock directories.
Disclaimer: The following news is paid for by third party on behalf of UV Flu Technologies, Inc., (eight hundred) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
C Van Zant: 800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com
More Investorideas Biotech Stocks info wwww.BiotechIndustryStocks.com - A Leading Global Investor Website for Biotech Industry Stocks, Biotech, Pharma and Industry News and Biotech Investor Research Tools including a Biotech Stocks Directory
Investorideas.com - Biotech Stock Alert; (OTCBB: UVFT) Reports Air Purifier Technology Fights Superbugs NDM-1
Visit this company: http://www.uvflutech.com/
CENTERVILLE, MA - September 27, 2010 (Investorideas.com newswire, http://www.biotechindustrystocks.com/ ) – Biotechnology Company News- UV Flu Technologies, Inc. ( OTC.BB:UVFT ) recently announced news that in response to recent outbreaks of drug resistant superbugs such as NDM-1, and persistent occurrences of highly contagious strains of bacteria such as MRSA, the Company is implementing a national campaign to inform the public how its ViraTech UV-400 indoor air purifier significantly helps reduce exposure risks.
Dr. Wladyslaw Jan Kowalski, PE, Phd, a world leading expert on the bacteria killing efficacy of ultraviolet light, recently commented on the UV-400: "Ultraviolet germicidal irradiation (UVGI) destroys bacteria by damaging the nucleic acids and thereby preventing reproduction. Multidrug-resistant microbes (superbugs) may have resistance to antibiotics but they remain as susceptible to ultraviolet radiation as any normal bacteria variant. The number of multidrug resistant microbes has been increasing, apparently due to overuse of antibiotics and other factors, and is expected to pose a serious challenge to health care facilities in the future as treatment options diminish."
Dr. Kowalski further added, "The ViraTech UV-400 model air cleaner has a demonstrated ability to disinfect air and inactivate a wide range of bacterial pathogens including Staphylococcus aureus (MRSA), Pseudomonas, and Klebsiella as has been conclusively demonstrated in independent laboratory tests. The UV-400 produces a germicidal UV exposure dose of 41 J/m(2), as independently verified by biodosimetric testing, which is sufficient to reduce pathogenic bacterial populations by at least 99%. This disinfection rate will apply regardless of the multidrug resistance of bacteria such as those that may contain the NDM-1 enzyme (the superbug gene). The ViraTech UV-400 unit provides a viable option for health care facilities struggling to cope with the growing problem of multidrug resistant organisms and this technology can serve as an adjunct to existing infection management procedures and disinfection protocols wherever the potential exists for microorganisms to spread by the airborne route."
"Our Company receives reports from around the world on an almost daily basis about the growing problems connected with the spread of these increasingly drug resistant bacterial strains," said Jack Lennon, President of UV Flu Technologies. "Antibiotics have become so pervasive in today's medical therapies, that not only are they becoming less effective, but their overuse is increasingly being considered as part of the problem. Drug-resistant superbugs have now been found in 20 states, as well as worldwide, and when they hit the critically ill, they can be fatal 30-60% of the time. In one recent incident at an infant ward at the University College Hospital in London, 15 babies in the unit were found to be carrying several types of bacteria, including 13 who had bacterial superbugs resistant to treatment. Of four babies seriously infected, one survived."
"So that the public can participate in actions to help reduce the spread of these strains, the Company has committed to advertising, including television and other media in order to educate consumers and to offer help where needed," said Mr. Lennon. "We are looking to develop a plan to offer our UV-400 indoor air quality units either free or at significantly discounted costs to those schools and hospitals that suffer from serious outbreaks. We hope to partner with institutions which are genuinely interested in working with us in order to develop an action plan for their facilities. For those with respiratory problems or weakened immune systems, hospital or institution acquired bacterial infections can prove deadly. We believe our product delivers an immediate, effective and proven ability to kill at least 99% of airborne bacteria thereby reducing the risk of infection."
Further details regarding the Company's business, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.
About UV Flu Technologies, Inc. (OTC.BB:UVFT)
UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector. The Company manufactures the ViraTech UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. VIRATECH UV-400 is a Class II medical device and is available without a prescription.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
UV Flu Technologies, Inc.John J. Lennon, President & CEO
Contact:Investor Information:Geaux IR Services, Inc.Toll-Free: 1-888-355-8838
Published at Investorideas.com and http://www.biotechindustrystocks.com/
Related industry commentary:
According to a recent article in Stltoday.com "The only antibiotics shown to work against NDM-1 are older-generation drugs that can have toxic side effects on a patient's kidneys. The drugs apparently work against the infections because they have not been circulating in the population for decades.Infection experts say new antibiotics are desperately needed to combat the growing field of superbugs.The Infectious Diseases Society of America has launched a "bad bugs need drugs" campaign to promote the development of 10 new antibiotics by 2020. The closest new antibiotic in development is still at least 18 months away from the market, Moenster said." Source: http://www.stltoday.com/lifestyles/health-med-fit/fitness/article_d0e57e62-22dc-55c7-96e1-300a858994f6.html
Disclaimer: The following news is paid for by third party on behalf of UV Flu Technologies, Inc., (eight hundred) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
More Info:
Published at http://www.investorideas.com/ - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Connect with Investorideas.com
Publish Your News - Send a release
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
More Investorideas Biotech Stocks info wwww.BiotechIndustryStocks.com - A Leading Global Investor Website for Biotech Industry Stocks, Biotech, Pharma and Industry News and Biotech Investor Research Tools including a Biotech Stocks Directory
Visit this company: http://www.uvflutech.com/
CENTERVILLE, MA - September 27, 2010 (Investorideas.com newswire, http://www.biotechindustrystocks.com/ ) – Biotechnology Company News- UV Flu Technologies, Inc. ( OTC.BB:UVFT ) recently announced news that in response to recent outbreaks of drug resistant superbugs such as NDM-1, and persistent occurrences of highly contagious strains of bacteria such as MRSA, the Company is implementing a national campaign to inform the public how its ViraTech UV-400 indoor air purifier significantly helps reduce exposure risks.
Dr. Wladyslaw Jan Kowalski, PE, Phd, a world leading expert on the bacteria killing efficacy of ultraviolet light, recently commented on the UV-400: "Ultraviolet germicidal irradiation (UVGI) destroys bacteria by damaging the nucleic acids and thereby preventing reproduction. Multidrug-resistant microbes (superbugs) may have resistance to antibiotics but they remain as susceptible to ultraviolet radiation as any normal bacteria variant. The number of multidrug resistant microbes has been increasing, apparently due to overuse of antibiotics and other factors, and is expected to pose a serious challenge to health care facilities in the future as treatment options diminish."
Dr. Kowalski further added, "The ViraTech UV-400 model air cleaner has a demonstrated ability to disinfect air and inactivate a wide range of bacterial pathogens including Staphylococcus aureus (MRSA), Pseudomonas, and Klebsiella as has been conclusively demonstrated in independent laboratory tests. The UV-400 produces a germicidal UV exposure dose of 41 J/m(2), as independently verified by biodosimetric testing, which is sufficient to reduce pathogenic bacterial populations by at least 99%. This disinfection rate will apply regardless of the multidrug resistance of bacteria such as those that may contain the NDM-1 enzyme (the superbug gene). The ViraTech UV-400 unit provides a viable option for health care facilities struggling to cope with the growing problem of multidrug resistant organisms and this technology can serve as an adjunct to existing infection management procedures and disinfection protocols wherever the potential exists for microorganisms to spread by the airborne route."
"Our Company receives reports from around the world on an almost daily basis about the growing problems connected with the spread of these increasingly drug resistant bacterial strains," said Jack Lennon, President of UV Flu Technologies. "Antibiotics have become so pervasive in today's medical therapies, that not only are they becoming less effective, but their overuse is increasingly being considered as part of the problem. Drug-resistant superbugs have now been found in 20 states, as well as worldwide, and when they hit the critically ill, they can be fatal 30-60% of the time. In one recent incident at an infant ward at the University College Hospital in London, 15 babies in the unit were found to be carrying several types of bacteria, including 13 who had bacterial superbugs resistant to treatment. Of four babies seriously infected, one survived."
"So that the public can participate in actions to help reduce the spread of these strains, the Company has committed to advertising, including television and other media in order to educate consumers and to offer help where needed," said Mr. Lennon. "We are looking to develop a plan to offer our UV-400 indoor air quality units either free or at significantly discounted costs to those schools and hospitals that suffer from serious outbreaks. We hope to partner with institutions which are genuinely interested in working with us in order to develop an action plan for their facilities. For those with respiratory problems or weakened immune systems, hospital or institution acquired bacterial infections can prove deadly. We believe our product delivers an immediate, effective and proven ability to kill at least 99% of airborne bacteria thereby reducing the risk of infection."
Further details regarding the Company's business, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.
About UV Flu Technologies, Inc. (OTC.BB:UVFT)
UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector. The Company manufactures the ViraTech UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. VIRATECH UV-400 is a Class II medical device and is available without a prescription.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
UV Flu Technologies, Inc.John J. Lennon, President & CEO
Contact:Investor Information:Geaux IR Services, Inc.Toll-Free: 1-888-355-8838
Published at Investorideas.com and http://www.biotechindustrystocks.com/
Related industry commentary:
According to a recent article in Stltoday.com "The only antibiotics shown to work against NDM-1 are older-generation drugs that can have toxic side effects on a patient's kidneys. The drugs apparently work against the infections because they have not been circulating in the population for decades.Infection experts say new antibiotics are desperately needed to combat the growing field of superbugs.The Infectious Diseases Society of America has launched a "bad bugs need drugs" campaign to promote the development of 10 new antibiotics by 2020. The closest new antibiotic in development is still at least 18 months away from the market, Moenster said." Source: http://www.stltoday.com/lifestyles/health-med-fit/fitness/article_d0e57e62-22dc-55c7-96e1-300a858994f6.html
Disclaimer: The following news is paid for by third party on behalf of UV Flu Technologies, Inc., (eight hundred) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
More Info:
Published at http://www.investorideas.com/ - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Connect with Investorideas.com
Publish Your News - Send a release
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
More Investorideas Biotech Stocks info wwww.BiotechIndustryStocks.com - A Leading Global Investor Website for Biotech Industry Stocks, Biotech, Pharma and Industry News and Biotech Investor Research Tools including a Biotech Stocks Directory
Friday, September 24, 2010
Investorideas.com - Biotechnology Products; UV Flu Technologies (OTC.BB: UVFT) UV-400 Air Purifier Fights Superbugs including NDM-1
Investorideas.com - Biotechnology Products; UV Flu Technologies (OTC.BB: UVFT) UV-400 Air Purifier Fights Superbugs including NDM-1
"Superbugs may have resistance to antibiotics but they remain as susceptible to ultraviolet radiation as any normal bacteria variant"- Dr. Wladyslaw Jan Kowalski, PE, Phd
Category: Investment, Biotech
Visit this company: www.uvflutech.com
CENTERVILLE, MA - September 24, 2010 (Investorideas.com newswire) - UV Flu Technologies, Inc. (OTC.BB:UVFT) reports that in response to recent outbreaks of drug resistant superbugs such as NDM-1, and persistent occurrences of highly contagious strains of bacteria such as MRSA, the Company is implementing a national campaign to inform the public how its ViraTech UV-400 indoor air purifier significantly helps reduce exposure risks.
Dr. Wladyslaw Jan Kowalski, PE, Phd, a world leading expert on the bacteria killing efficacy of ultraviolet light, recently commented on the UV-400: "Ultraviolet germicidal irradiation (UVGI) destroys bacteria by damaging the nucleic acids and thereby preventing reproduction. Multidrug-resistant microbes (superbugs) may have resistance to antibiotics but they remain as susceptible to ultraviolet radiation as any normal bacteria variant. The number of multidrug resistant microbes has been increasing, apparently due to overuse of antibiotics and other factors, and is expected to pose a serious challenge to health care facilities in the future as treatment options diminish."
Dr. Kowalski further added, "The ViraTech UV-400 model air cleaner has a demonstrated ability to disinfect air and inactivate a wide range of bacterial pathogens including Staphylococcus aureus (MRSA), Pseudomonas, and Klebsiella as has been conclusively demonstrated in independent laboratory tests. The UV-400 produces a germicidal UV exposure dose of 41 J/m(2), as independently verified by biodosimetric testing, which is sufficient to reduce pathogenic bacterial populations by at least 99%. This disinfection rate will apply regardless of the multidrug resistance of bacteria such as those that may contain the NDM-1 enzyme (the superbug gene). The ViraTech UV-400 unit provides a viable option for health care facilities struggling to cope with the growing problem of multidrug resistant organisms and this technology can serve as an adjunct to existing infection management procedures and disinfection protocols wherever the potential exists for microorganisms to spread by the airborne route."
"Our Company receives reports from around the world on an almost daily basis about the growing problems connected with the spread of these increasingly drug resistant bacterial strains," said Jack Lennon, President of UV Flu Technologies. "Antibiotics have become so pervasive in today's medical therapies, that not only are they becoming less effective, but their overuse is increasingly being considered as part of the problem. Drug-resistant superbugs have now been found in 20 states, as well as worldwide, and when they hit the critically ill, they can be fatal 30-60% of the time. In one recent incident at an infant ward at the University College Hospital in London, 15 babies in the unit were found to be carrying several types of bacteria, including 13 who had bacterial superbugs resistant to treatment. Of four babies seriously infected, one survived."
"So that the public can participate in actions to help reduce the spread of these strains, the Company has committed to advertising, including television and other media in order to educate consumers and to offer help where needed," said Mr. Lennon. "We are looking to develop a plan to offer our UV-400 indoor air quality units either free or at significantly discounted costs to those schools and hospitals that suffer from serious outbreaks. We hope to partner with institutions which are genuinely interested in working with us in order to develop an action plan for their facilities. For those with respiratory problems or weakened immune systems, hospital or institution acquired bacterial infections can prove deadly. We believe our product delivers an immediate, effective and proven ability to kill at least 99% of airborne bacteria thereby reducing the risk of infection."
Further details regarding the Company's business, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.
About UV Flu Technologies, Inc. (OTC.BB:UVFT)
UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector. The Company manufactures the ViraTech UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. VIRATECH UV-400 is a Class II medical device and is available without a prescription.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
UV Flu Technologies, Inc.
John J. Lennon, President & CEO
Contact:
Investor Information:Geaux IR Services, Inc.Toll-Free: 1-888-355-8838investors@uvflutech.com
Disclaimer: The following news is paid for by third party on behalf of UV Flu Technologies, Inc., (eight hundred) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Connect with Investorideas.com
Publish Your News - Send a release
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
"Superbugs may have resistance to antibiotics but they remain as susceptible to ultraviolet radiation as any normal bacteria variant"- Dr. Wladyslaw Jan Kowalski, PE, Phd
Category: Investment, Biotech
Visit this company: www.uvflutech.com
CENTERVILLE, MA - September 24, 2010 (Investorideas.com newswire) - UV Flu Technologies, Inc. (OTC.BB:UVFT) reports that in response to recent outbreaks of drug resistant superbugs such as NDM-1, and persistent occurrences of highly contagious strains of bacteria such as MRSA, the Company is implementing a national campaign to inform the public how its ViraTech UV-400 indoor air purifier significantly helps reduce exposure risks.
Dr. Wladyslaw Jan Kowalski, PE, Phd, a world leading expert on the bacteria killing efficacy of ultraviolet light, recently commented on the UV-400: "Ultraviolet germicidal irradiation (UVGI) destroys bacteria by damaging the nucleic acids and thereby preventing reproduction. Multidrug-resistant microbes (superbugs) may have resistance to antibiotics but they remain as susceptible to ultraviolet radiation as any normal bacteria variant. The number of multidrug resistant microbes has been increasing, apparently due to overuse of antibiotics and other factors, and is expected to pose a serious challenge to health care facilities in the future as treatment options diminish."
Dr. Kowalski further added, "The ViraTech UV-400 model air cleaner has a demonstrated ability to disinfect air and inactivate a wide range of bacterial pathogens including Staphylococcus aureus (MRSA), Pseudomonas, and Klebsiella as has been conclusively demonstrated in independent laboratory tests. The UV-400 produces a germicidal UV exposure dose of 41 J/m(2), as independently verified by biodosimetric testing, which is sufficient to reduce pathogenic bacterial populations by at least 99%. This disinfection rate will apply regardless of the multidrug resistance of bacteria such as those that may contain the NDM-1 enzyme (the superbug gene). The ViraTech UV-400 unit provides a viable option for health care facilities struggling to cope with the growing problem of multidrug resistant organisms and this technology can serve as an adjunct to existing infection management procedures and disinfection protocols wherever the potential exists for microorganisms to spread by the airborne route."
"Our Company receives reports from around the world on an almost daily basis about the growing problems connected with the spread of these increasingly drug resistant bacterial strains," said Jack Lennon, President of UV Flu Technologies. "Antibiotics have become so pervasive in today's medical therapies, that not only are they becoming less effective, but their overuse is increasingly being considered as part of the problem. Drug-resistant superbugs have now been found in 20 states, as well as worldwide, and when they hit the critically ill, they can be fatal 30-60% of the time. In one recent incident at an infant ward at the University College Hospital in London, 15 babies in the unit were found to be carrying several types of bacteria, including 13 who had bacterial superbugs resistant to treatment. Of four babies seriously infected, one survived."
"So that the public can participate in actions to help reduce the spread of these strains, the Company has committed to advertising, including television and other media in order to educate consumers and to offer help where needed," said Mr. Lennon. "We are looking to develop a plan to offer our UV-400 indoor air quality units either free or at significantly discounted costs to those schools and hospitals that suffer from serious outbreaks. We hope to partner with institutions which are genuinely interested in working with us in order to develop an action plan for their facilities. For those with respiratory problems or weakened immune systems, hospital or institution acquired bacterial infections can prove deadly. We believe our product delivers an immediate, effective and proven ability to kill at least 99% of airborne bacteria thereby reducing the risk of infection."
Further details regarding the Company's business, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.
About UV Flu Technologies, Inc. (OTC.BB:UVFT)
UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector. The Company manufactures the ViraTech UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. VIRATECH UV-400 is a Class II medical device and is available without a prescription.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
UV Flu Technologies, Inc.
John J. Lennon, President & CEO
Contact:
Investor Information:Geaux IR Services, Inc.Toll-Free: 1-888-355-8838investors@uvflutech.com
Disclaimer: The following news is paid for by third party on behalf of UV Flu Technologies, Inc., (eight hundred) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Connect with Investorideas.com
Publish Your News - Send a release
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Subscribe to:
Posts (Atom)